Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease
Open accessAbstract
Trimethylamine N-oxide (TMAO) is a biologically active molecule and is a putative promoter of chronic diseases including atherosclerosis in humans. Host intestinal bacteria produce its precursor trimethylamine (TMA) from carnitine, choline, or choline-containing compounds. Most of the TMA produced is passively absorbed into portal circulation, and hepatic flavin-dependent monooxygenases (FMOs) efficiently oxidize TMA to TMAO. Both observational and experimental studies suggest a strong positive correlation between increased plasma TMAO concentrations and adverse cardiovascular events, such as myocardial infarction, stroke, and death. However, a clear mechanistic link between TMAO and such diseases is not yet validated. Therefore, it is debated whether increased TMAO concentrations are the cause or result of these diseases. Here, we have tried to review the current understanding of the properties and physiological functions of TMAO, its dietary sources, and its effects on human metabolism. Studies that describe the potential role of TMAO in the etiology of cardiovascular and other diseases are also discussed.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 214 cited sources checked · 0 supported · 0 flagged
- Premisenone given
Observational and experimental studies indicate a strong positive relationship between higher plasma TMAO and adverse cardiovascular events such as myocardial infarction, stroke, and death.
“Both observational and experimental studies suggest a strong positive correlation between increased plasma TMAO concentrations and adverse cardiovascular events, such as myocardial infarction, stroke, and death.”
Quote in the paperSubstantial claim - Premisenone given
Intestinal bacteria in the host make TMA from carnitine, choline, or choline-containing compounds.
“Host intestinal bacteria produce its precursor trimethylamine (TMA) from carnitine, choline, or choline-containing compounds.”
Quote in the paperSubstantial claim - Interpretationnone given
A clear mechanistic link between TMAO and diseases such as atherosclerosis has not yet been validated.
“However, a clear mechanistic link between TMAO and such diseases is not yet validated.”
Quote in the paperSubstantial claim - Premisecitation
Men with greater Firmicutes-to-Bacteroidetes enrichment produced more TMA after a challenge meal.
“A recent study in men observed that people with higher Firmicutes to Bacteroidetes enrichment generated more TMA after a challenge meal (28).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28] source
Not checked in the free run.
- Premisecitation
Gut microbiota are necessary for dietary choline, choline-containing compounds, betaine, and L-carnitine to be converted to TMA.
“We know that gut microbiota are required for these nutrients to be converted to TMA because gnotobiotic mice do not produce such TMA (1,96), and antibiotic treatment of standard mice decreases TMA formation (1).”
Quote in the paperSubstantial claim0 of 2 sources checked
- Premisecitation
Oral flora Streptococcus sanguis can produce TMA from choline.
“oral flora (Streptococcus sanguis, a facultative anaerobe) also can form TMA from choline (25).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] source
Not checked in the free run.
- Premisenone given
The YeaW/YeaX gene pair encodes oxygenase and oxidoreductase activities with broad substrate use for γ-butyrobetaine, L-carnitine, choline, and betaine.
“A YeaW/YeaX gene pair encodes for oxygenase and oxidoreductase activities that have substrate promiscuity for γ-butyrobetaine, L-carnitine, choline, and betaine.”
Quote in the paperNot a substantial claim - Premisecitation
FMO3 has tenfold higher specific activity in liver than FMO1.
“FMO3 has tenfold higher specific activity in the liver than does FMO1 (13).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] source
Not checked in the free run.
- Premisecitation
Cholic acid induces FMO3 through the bile acid-activated nuclear receptor FXR.
“The bile salt, cholic acid, induces FMO3 via the bile acid-activated nuclear receptor FXR (13).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] source
Not checked in the free run.
- Premisecitation
A choline-utilization gene cluster responsible for anaerobic conversion of choline to TMA was identified in Desulfovibrio desulfuricans.
“A choline-utilization gene cluster (Cut) responsible for anaerobic conversion of choline to TMA was identified in the sulfate-reducing bacterium Desulfovibrio desulfuricans (32,112).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Menstrual trimethylaminuria is more pronounced in women homozygous for variants that mildly reduce FMO3 enzyme activity.
“This menstrual trimethylaminuria is more pronounced in women homozygous for variants that result in a mild decrease in FMO3 enzyme activity (103).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [103] source
Not checked in the free run.
- Premisecitation
Edwardsiella tarda produces TMA even though it does not express the TMA-producing genes discussed.
“Only Edwardsiella tarda does not express the TMA-producing genes discussed in Section 1 above but produces TMA nonetheless (96).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [96] source
Not checked in the free run.
- Premisecitation
The EPIC-Heidelberg study found that fasting plasma TMAO varied more within individuals over one year than between people.
“The European Prospective Investigation into Cancer and Nutrition (EPIC)-Heidelberg study evaluated individual variations in fasting plasma TMAO concentrations for one year.TMAO concentration varied within each individual over time more than it did between people (66).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [66] source
Not checked in the free run.
- Premisecitation
In human plasma, physiological TMAO concentrations are about 10- to 20-fold higher than TMA concentrations.
“Physiological concentration ranges for TMAO are ≈10to 20-fold higher than are those for TMA in human plasma (99).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [99] source
Not checked in the free run.
- Premisecitation
A microbial pathway that produces TMA and malic semialdehyde from L-carnitine hydroxylation is active in human colon isolates of Acinetobacter and Serratia.
“A microbial metabolic pathway generating TMA and malic semialdehyde from L-carnitine hydroxylation are active in human colon isolates belonging to the genera Acinetobacter and Serratia (41).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] source
Not checked in the free run.
- Premisecitation
A second carnitine-to-TMA pathway goes through γ-butyrobetaine in the ileum and then converts γ-butyrobetaine to TMA in the cecum and colon.
“A second pathway converting carnitine to TMA involves production of the intermediate γ-butyrobetaine in the ileum, with subsequent conversion of γ-butyrobetaine to TMA in the cecum and colon (62).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [62] source
Not checked in the free run.
- Premisecitation
TMAO influences both lipid and glucose homeostasis.
“TMAO modulates both lipid and glucose homeostasis”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] source
Not checked in the free run.
- Premisecitation
In rats, urinary TMAO excretion is limited by elimination rather than formation rate.
“It is interesting that, in rats, urinary TMAO excretion was elimination-and not formation-rate limited (88).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [88] source
Not checked in the free run.
- Premisecitation
The rise in TMAO concentrations is not completely concordant with the reduction in estimated glomerular filtration rate.
“However, the degree of rise in TMAO concentrations was not completely concordant with the degree of reduction in the estimated glomerular filtration rate (eGFR) (108).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [108] source
Not checked in the free run.
- Premisecitation
About 95% of TMA is oxidized and excreted in urine in a 3:95 TMA:TMAO ratio.
“about 95% of TMA is oxidized as it is subsequently excreted in urine in a 3:95 TMA:TMAO ratio (132).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [132] source
Not checked in the free run.
- Premisecitation
The choline-to-TMA pathway involves radical C-N bond cleavage of choline to produce TMA and acetaldehyde.
“The pathway involves a radical C-N bond cleavage of choline to generate TMA and acetaldehyde (32).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] source
Not checked in the free run.
- Premisecitation
A large study found that women form less TMAO than men.
“In fact, a large study reported that women have less TMAO formation than do men (89).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [89] source
Not checked in the free run.
- Premisecitation
CutC and CutD are essential for converting choline to TMA.
“Deletion of the CutC gene in Desulfovibrio alaskensis G20 and heterologous expression of the CutC and CutD genes from D. alaskensis G20 in Escherichia coli confirmed that these genes are essential for the conversion of choline to TMA (32).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] source
Not checked in the free run.
- Premisenone given
FMO3 catalyzes NADPH-dependent oxygenation of TMA.
“FMO3 catalyzes NADPH-dependent oxygenation of TMA.”
Quote in the paperSubstantial claim - Premisecitation
Dietary Crucifera can lower FMO3 enzyme activity.
“Dietary Crucifera can decrease FMO3 enzyme activity.”
Quote in the paperNot a substantial claim - Premisecitation
CntA and CntB encode a two-subunit oxidoreductase that converts L-carnitine to TMA.
“Two genes, CntA and CntB, encode a two-subunit oxidoreductase (A encodes the carnitine oxidase, and B encodes a reductase) for L-carnitine conversion to TMA (confirmed by a series of knockout and heterologous expression experiments) (137).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [137] source
Not checked in the free run.
- Premisenone given
TMA is obtained from bacterial metabolism of dietary L-carnitine and its metabolite γ-butyrobetaine.
“TMA is obtained from bacterial metabolism of dietary L-carnitine (and its metabolite γbutyrobetaine).”
Quote in the paperSubstantial claim - Premisecitation
In experiments on pH-induced hysteretic processes of ischemic myocardium, TMAO increased the reactivation rate of phosphofructokinase purified from rat myocardium.
“In experiments designed to investigate pH-induced hysteretic processes of ischemic myocardium, TMAO increased the rate of reactivation of the phosphofructokinase enzyme purified from rat myocardium (47).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Hand SC, 1986, Am. J. Physiol.
Not checked in the free run.
- Premisecitation
TMA is also obtained from bacterial metabolism of dietary betaine.
“TMA also is obtained from bacterial metabolism of dietary betaine (120).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [120] source
Not checked in the free run.
- Premisecitation
TMA can be present in commercially available fish oil or choline-containing supplements that have undergone bacterial degradation during preparation or storage.
“In addition, TMA can be present in commercially available fish oil or choline-containing diet supplements that have been subject to bacterial degradation during preparation or storage (131).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [131] Zeisel SH, 1983, J. Pharmacol. Exp. Ther. source
Not checked in the free run.
- Premisecitation
TMAO may signal through activation of mitogen-activated protein kinase and nuclear factor-κB pathways.
“TMAO also may signal via activation of mitogen-activated protein kinase and nuclear factor-κB (NF-κB) pathways (99, 136).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Suppressing intestinal microbiota completely inhibited diet-dependent reductions in reverse cholesterol transport.
“Suppression of intestinal microbiota (and therefore plasma TMAO concentrations) completely inhibited diet-dependent reductions in RCT.”
Quote in the paperSubstantial claim - Premisecitation
In Swedish men, fish consumption was associated with higher urinary TMAO concentrations.
“In a study of Swedish men, fish consumption was associated with increased urinary TMAO concentrations (107).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [107] source
Not checked in the free run.
- Premisecitation
After an L-carnitine challenge, people produced TMAO from L-carnitine in a gut microbe-dependent manner.
“After administration of an L-carnitine challenge test (consumption of a diet containing an 8-ounce sirloin steak and a capsule containing 250 mg of a heavy isotope-labeled L-carnitine), people produced TMAO from L-carnitine in a gut microbe-dependent manner (63).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [63] source
Not checked in the free run.
- Premisecitation
Higher TMAO concentrations reduce loss of catalytic activity of rabbit muscle phosphofructokinase under pH-induced cold lability.
“Increased TMAO concentrations reduce the loss of catalytic activity of rabbit muscle phosphofructokinase under conditions of pH-induced cold lability (48).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48] Hand SC, 1982, J. Biol. Chem. source
Not checked in the free run.
- Premisecitation
Consuming at least two eggs, which contain mostly PtdCho, increases TMAO formation.
“However, consumption of ≥2 eggs, which contain mostly PtdCho, results in increased formation of TMAO (79,110).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisenone given
TMA can be produced by bacterial metabolism of dietary choline and choline-containing compounds such as PtdCho.
“TMA can be produced from bacterial metabolism of dietary choline and choline-containing compounds, such as PtdCho.”
Quote in the paperSubstantial claim - Premisecitation
TMAO stimulated the association of phosphorylase kinase with its substrate glycogen.
“In accord with its projected role as a chemical chaperone and nanocrowding particle (29), TMAO stimulated the association of the enzyme phosphorylase kinase with its substrate glycogen (26).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [26] Chebotareva NA, 2007, Biochemistry
Not checked in the free run.
- Premisenone given
Only the L-stereoisomer of carnitine occurs in foods.
“Only the L-stereoisomer of carnitine is found in foods.”
Quote in the paperNot a substantial claim - Premisenone given
TMAO regulates multiple aspects of cholesterol and sterol metabolism.
“TMAO regulates multiple aspects of cholesterol and sterol metabolism (Figure 2).”
Quote in the paperSubstantial claim - Premisecitation
After an egg-containing meal, plasma TMAO peaks at 6 to 8 h and returns to baseline by 24 h.
“After people consume a meal containing eggs, TMAO concentrations in plasma peak at 6 to 8 h and return to baseline by 24 h after the meal (79).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [79] source
Not checked in the free run.
- Premisecitation
In obese patients undergoing bariatric surgery, TMAO concentrations were moderately increased after surgery.
“In obese patients undergoing bariatric surgery, TMAO concentrations were moderately increased after surgery (114).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [114] source
Not checked in the free run.
- Premisecitation
Similar reductions in hepatic lipids, plasma lipids, ketone bodies, glucose, and insulin occurred in FMO3 antisense oligonucleotide-treated LDL receptor knockout mice.
“Similar reductions in hepatic lipids, plasma lipids, ketone bodies, glucose, and insulin were also seen in FMO3 antisense oligonucleotide (ASO)-treated LDL receptor knockout mice (102).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [102] source
Not checked in the free run.
- Premisecitation
Transcript levels of hepatic bile acid transporters Oatp1, Oatp4, Mrp2, and Ntcp were significantly reduced by TMAO feeding.
“Transcript levels of hepatic bile acid transporters, such as Oatp1, Oatp4, Mrp2, and Ntcp, also showed significant reductions in response to TMAO feeding (118).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [118] source
Not checked in the free run.
- Premisecitation
In the Jackson Heart Study, higher betaine intake was associated with a nonlinear higher risk of incident coronary heart disease.
“In the Jackson Heart Study, involving 3,924 African-Americans, higher dietary choline was associated with reduced risk of incident ischemic stroke, whereas higher betaine intake was associated with a nonlinear higher risk of incident coronary heart disease (78).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [78] 78. Millard HR, Musani SK, Dibaba DT, Talegawkar SA, Taylor HA, et al. 2016. Dietary choline and betaine; associations with subclinical markers of cardiovascular disease risk and incidence of CVD, coronary heart disease and stroke: the Jackson Heart Study. Eur. J. Nutr. doi:10.1007/s00394-016-1296-8 source
Not checked in the free run.
- Premisecitation
A meta-analysis of 13 controlled trials (n=3,629) reported that low oral L-carnitine reduced all-cause mortality by 27% in acute myocardial infarction patients.
“A meta-analysis of 13 controlled trials (n = 3,629 people) reported that low oral dosage of L-carnitine resulted in 27% reduction in all-cause mortality, a 65% reduction in ventricular arrhythmias, and a 40% reduction in angina symptoms in patients who had an acute myocardial infarction (37).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [37] source
Not checked in the free run.
- Premisecitation
Feeding L-carnitine to Apoe-/- transgenic mice overexpressing human CETP increased plasma TMAO.
“Feeding L-carnitine to Apo e -/- transgenic mice overexpressing human cholesterol ester transfer protein (CETP) caused increased plasma TMAO concentrations in these mice, but this elevated TMAO was inversely correlated with aortic lesion size (31).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] source
Not checked in the free run.
- Premisecitation
In those CETP-overexpressing mice, elevated TMAO was inversely correlated with aortic lesion size.
“Feeding L-carnitine to Apo e -/- transgenic mice overexpressing human cholesterol ester transfer protein (CETP) caused increased plasma TMAO concentrations in these mice, but this elevated TMAO was inversely correlated with aortic lesion size (31).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] source
Not checked in the free run.
- Premisecitation
Antibiotic treatment prevented the proatherogenic effects of choline, γ-butyrobetaine, and carnitine in mice.
“The proatherogenic effects of choline, γ-butyrobetaine, and carnitine were prevented by treatment with antibiotics, suggesting that microbial metabolism of these precursors was required for the effect (63, 118).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Dietary TMAO supplementation did not normalize cholesterol balance.
“However, dietary supplementation of TMAO failed to normalize cholesterol balance.”
Quote in the paperSubstantial claim - Premisecitation
In >17,000 postmenopausal Dutch women in PROSPECT-EPIC, dietary betaine and choline were not associated with CVD risk.
“Dietary intakes of betaine and choline were not associated with CVD risk in >17,000 postmenopausal Dutch women in the PROSPECT-EPIC cohort (34).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] source
Not checked in the free run.
- Premisecitation
Oral L-carnitine supplementation increased plasma TMAO in hemodialysis patients.
“Although oral supplementation of L-carnitine was associated with increased plasma TMAO concentrations, it decreased vascular injury markers and oxidative stress markers in hemodialysis patients (43).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] source
Not checked in the free run.
- Premisecitation
In 4,007 patients who had elective coronary angiography, higher plasma TMAO levels were linked to greater risk of major adverse cardiovascular events over three years.
“During three years of follow-up in patients (n = 4,007) undergoing elective coronary angiography, increased plasma concentrations of TMAO were associated with increased risks of major adverse cardiovascular events (110).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [110] source
Not checked in the free run.
- Premisecitation
In 292 individuals (99 CVD cases, 193 controls), plasma TMAO was significantly correlated with prevalent CVD after adjustment for covariates including meat, fish, cholesterol, and energy intake.
“In 292 individuals (99 CVD cases and 193 unmatched control subjects), plasma TMAO concentrations were significantly correlated with prevalent CVD, even after accounting for covariates, such as meat, fish, cholesterol, and energy intake (75).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [75] source
Not checked in the free run.
- Premisecitation
Modest but significant increases in cholesterol transporters such as Abca1 and Abcg1 were observed.
“In fact, modest but significant increases in many cholesterol transporters, such as Abca1 and Abcg1, were noted (118).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [118] source
Not checked in the free run.
- Premisecitation
Feeding γ-butyrobetaine, a carnitine metabolite, increased aortic plaque size in mice.
“Feeding the TMAO precursor γ-butyrobetaine (a metabolite of carnitine) also increased aortic plaque size (62).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [62] source
Not checked in the free run.
- Premisecitation
In the Atherosclerosis Risk in Communities Study (n=14,430 middle-aged people), dietary choline or betaine intake was not associated with incident CVD.
“No association was found between dietary choline or betaine intake and incident CVD in the Atherosclerosis Risk in Communities Study (n = 14,430 middle-aged people) (16).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] source
Not checked in the free run.
- Premisecitation
In the Jackson Heart Study (3,924 African-Americans), higher dietary choline was associated with reduced risk of incident ischemic stroke.
“In the Jackson Heart Study, involving 3,924 African-Americans, higher dietary choline was associated with reduced risk of incident ischemic stroke, whereas higher betaine intake was associated with a nonlinear higher risk of incident coronary heart disease (78).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [78] 78. Millard HR, Musani SK, Dibaba DT, Talegawkar SA, Taylor HA, et al. 2016. Dietary choline and betaine; associations with subclinical markers of cardiovascular disease risk and incidence of CVD, coronary heart disease and stroke: the Jackson Heart Study. Eur. J. Nutr. doi:10.1007/s00394-016-1296-8 source
Not checked in the free run.
- Premisecitation
In an EPIC study of >400,000 people, processed meat was positively correlated with CVD mortality.
“There was a positive correlation between processed meat and mortality due to CVD observed in a study from the EPIC group (n > 400,000 people), but this association was specific to processed meat and was not seen with unprocessed meat, which has high L-carnitine and choline content (95).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [95] source
Not checked in the free run.
- Premisenone given
Accumulating evidence suggests an association between TMAO and risk for developing atherosclerotic cardiovascular disease.
“As discussed above in Section 1, there is accumulating evidence suggesting an association between TMAO and risk for developing atherosclerotic CVD.”
Quote in the paperSubstantial claim - Premisecitation
In atherosclerosis-prone C57BL/6J Apoe-/- mice, a normal diet supplemented with choline, L-carnitine, or TMAO increased total aortic root atherosclerotic plaque area compared with control diet.
“Atherosclerosis-prone mice (C57BL/6J Apo e -/-) fed a normal diet supplemented with additional choline (118) and L-carnitine (63) or TMAO (118) had increased total aortic root atherosclerotic plaque area compared with mice fed a control diet (118).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
In 2,235 patients with stable coronary artery disease, elevated plasma TMAO was associated with greater long-term mortality risk.
“The prognostic value of plasma TMAO concentrations was assessed in a cohort of patients (n = 2,235) with stable coronary artery disease, and elevated concentrations were associated with greater long-term mortality risk (101).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [101] source
Not checked in the free run.
- Premisecitation
Plasma TMAO was strongly associated with long-term mortality in heart failure patients.
“Plasma TMAO concentrations were strongly associated with long-term mortality in heart failure patients, with advanced left-ventricular diastolic dysfunction, and with atherosclerosis burden in patients with atherosclerotic coronary artery disease (100, 101, 109, 111, 120).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
In stable cardiac patients, elevated plasma choline and betaine were associated with incident mortality, myocardial infarction, and stroke risk, independent of traditional risk factors.
“Elevated concentrations of plasma choline and betaine, assessed in stable cardiac patients, were associated with incident mortality, myocardial infarction, and stroke risk, independent of other traditional risk factors.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [120] source
Not checked in the free run.
- Premisecitation
In that cohort, TMAO concentrations were not associated with incidence or symptoms of coronary heart disease.
“In a cohort of 339 patients who underwent coronary angiography, plasma concentrations of TMAO or choline were significantly increased with decreasing renal function, but TMAO concentrations were not associated with incidence or symptoms of coronary heart disease.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [85] source
Not checked in the free run.
- Premisecitation
In 339 patients who had coronary angiography, plasma TMAO or choline increased significantly as renal function decreased.
“In a cohort of 339 patients who underwent coronary angiography, plasma concentrations of TMAO or choline were significantly increased with decreasing renal function, but TMAO concentrations were not associated with incidence or symptoms of coronary heart disease.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [85] source
Not checked in the free run.
- Premisecitation
In a transverse aortic constriction mouse model, a choline (1.2%)/TMAO (0.12%)-enriched diet significantly increased plasma TMAO and worsened pulmonary edema, cardiac enlargement, myocardial fibrosis, and left ventricular ejection fraction.
“In the transverse aortic constriction surgical mouse model for pressure overload-induced heart failure, a choline (1.2%)/TMAO (0.12%)-enriched diet significantly increased plasma TMAO concentrations and worsened pulmonary edema, cardiac enlargement, myocardial fibrosis, and left ventricular ejection fraction (90).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [90] source
Not checked in the free run.
- Premisecitation
Choline and betaine were predictive only when plasma TMAO also increased simultaneously.
“However, these metabolites were predictive only when a simultaneous increase in plasma TMAO concentrations was observed (120).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [120] source
Not checked in the free run.
- Premisecitation
In 227 patients who had cardiovascular surgery for coronary, valvular, or aortic disease, the highest quartile of plasma TMAO had a significantly greater number of infarcted coronary arteries than the lowest quartile (OR 11.9, 95% CI 3.88-36.7, p≤0.001).
“In a cross-sectional study of 227 patients who underwent cardiovascular surgery for coronary artery disease, valvular heart disease, or aortic disease, a significantly increased number of infarcted coronary arteries was identified in patients in the highest quartile of plasma TMAO concentrations compared to the lowest quartile (odds ratio 11.9; 95% confidence interval 3.88-36.7,p value ≤ 0.001) (”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [72] source
Not checked in the free run.
- Interpretationcitation
The prevention by antibiotics suggests microbial metabolism of these precursors was required for the proatherogenic effect.
“The proatherogenic effects of choline, γ-butyrobetaine, and carnitine were prevented by treatment with antibiotics, suggesting that microbial metabolism of these precursors was required for the effect (63, 118).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Higher dietary PtdCho intake was associated with increased mortality risk in women in the Nurses' Health Study and men in the Health Professionals Follow-Up Study.
“Higher dietary intake of PtdCho, another precursor for TMAO formation, was associated with increased mortality risk in an analysis of 80,978 women from the Nurses' Health Study (1980-2012) and 39,434 men from the Health Professionals Follow-Up Study (1986-2012) (135).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [135] source
Not checked in the free run.
- Premisecitation
Plasma L-carnitine concentrations in subjects undergoing cardiac evaluation (n = 2,595) predicted increased risks for cardiovascular disease and major adverse cardiac events including myocardial infarction, stroke, and death.
“In addition, plasma concentrations of the TMAO precursor L-carnitine in subjects undergoing cardiac evaluation (n = 2,595) predicted increased risks for CVD and for major adverse cardiac events (myocardial infarction, stroke, and death) (63).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [63] source
Not checked in the free run.
- Premisecitation
Many studies linking TMAO to heart disease also found that people with higher TMAO had decreased renal function.
“Many of the studies that identified an association between TMAO and heart disease also found that people with higher TMAO had decreased renal function (61,109).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationcitation
A large body of evidence links fish consumption to cardio-protective effects.
“In fact, a large body of evidence links fish consumption to cardio-protective effects.”
Quote in the paperSubstantial claim - Premisecitation
Elevated plasma TMAO predicted five-year mortality after adjustment for traditional risk factors.
“Elevated plasma TMAO concentrations were predictive of five-year mortality risk after adjusting for traditional risk factors, such as high-sensitivity C-reactive protein, glomerular filtration rate, etc.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [109] source
Not checked in the free run.
- Interpretationreasoning
Studies in mouse models and cell culture provide key evidence that a causal relationship between TMAO and CVD could exist.
“Randomized intervention trials with TMAO do not exist, but several studies in mouse models and cell culture, discussed above in Sections 5.1.2and 5.1.3,provide key evidence that there could be a causal relationship between TMAO and CVD.”
Quote in the paperSubstantial claim - Premisecitation
The effects of TMAO on atherogenesis are completely opposite in Apoe-/- transgenic mice overexpressing human CETP.
“As discussed above in Section 5.1.2,the effects of TMAO on atherogenesis are completely opposite when Apo e -/-transgenic mice overexpressing human CETP are studied.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] source
Not checked in the free run.
- Interpretationnone given
Most, but not all, human observational studies support an association between high plasma TMAO and CVD risk, especially atherosclerosis.
“Most, but not all, human observational studies support the hypothesis that there is an association between high plasma TMAO concentrations and risk for CVD, especially atherosclerosis.”
Quote in the paperSubstantial claim - Premisecitation
In those CETP-overexpressing mice, increased plasma TMAO was inversely correlated with aortic lesion size.
“In these mice, increased plasma TMAO concentrations were inversely correlated with aortic lesion size (31).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31] source
Not checked in the free run.
- Premisecitation
Plasma TMA and TMAO were significantly higher in 15 end-stage renal disease patients than in 15 healthy controls.
“Significantly higher concentrations of TMA and TMAO were noted in plasma from 15 patients with end-stage renal disease compared to 15 healthy counterparts (8).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] source
Not checked in the free run.
- Premisecitation
Patients with poor kidney function have elevated plasma TMAO concentrations.
“Patients with poor kidney function have elevated plasma TMAO concentrations (93,109).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Mice lack cholesteryl ester transfer protein, which transfers cholesterol ester from HDL to VLDL and LDL.
“Mice lack the cholesteryl ester transfer protein that transfers cholesterol ester from HDL to very low-density lipoprotein (VLDL) and LDL (57).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Jawien J, 2004, J. Physiol. Pharmacol.
Not checked in the free run.
- Premisecitation
Peritoneal macrophages from C57BL/6J mice fed a TMAO-supplemented diet for more than three weeks showed increased mRNA levels of CD36 and SR-A1.
“Peritoneal macrophages obtained from C57BL/6J mice, fed a TMAO-supplemented diet for more than three weeks, showed increased mRNA levels of two macrophage scavenger receptors (CD36 and SR-A1), which are implicated in atherosclerosis (118).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [118] source
Not checked in the free run.
- Premisecitation
In 16 patients, magnetic resonance spectroscopy showed plasma TMAO correlated with degree of renal failure.
“Magnetic resonance spectroscopy in 16 patients observed that plasma TMAO concentrations were correlated with the degree of renal failure (12).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] source
Not checked in the free run.
- Premisecitation
An analysis of 26 prospective cohort studies and 12 RCTs (794,000 people, 34,817 cerebrovascular outcomes) found dietary fish intake protective against stroke.
“In an analysis of 26 prospective cohort studies and 12 randomized controlled trials with aggregate data on 794,000 nonoverlapping people and 34,817 cerebrovascular outcomes, dietary fish intake was protective against stroke (30).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [30] source
Not checked in the free run.
- Premisecitation
In the Physicians Health Study, no evidence of association was found between fish consumption and any type of CVD events.
“In the Physicians Health Study, no evidence of association was found between fish consumption and any type of CVD events (3).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] source
Not checked in the free run.
- Premisecitation
In a metabolomic analysis of urine from 31 patients, plasma TMAO was higher in CKD than non-CKD.
“Metabolomic analysis of urine from 31 patients identified a group of seven metabolites that differed between chronic kidney disease (CKD) and non-CKD urine samples; TMAO concentrations in plasma were higher in CKD (92).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [92] source
Not checked in the free run.
- Premisecitation
Renal transplantation corrects the high plasma TMAO seen in renal failure.
“Renal transplantation corrects the high plasma TMAO concentrations seen in renal failure (81,106).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisenone given
Randomized intervention trials with TMAO do not exist.
“Randomized intervention trials with TMAO do not exist, but several studies in mouse models and cell culture, discussed above in Sections 5.1.2and 5.1.3,provide key evidence that there could be a causal relationship between TMAO and CVD.”
Quote in the paperSubstantial claim - Interpretationreasoning
Such associations do not necessarily mean TMAO causes heart disease.
“However, such associations do not mean, necessarily, that TMAO causes heart disease.”
Quote in the paperNot a substantial claim - Premisecitation
Hemodialysis efficiently removed TMAO from blood.
“Serum concentration of TMAO was inversely associated with eGFR and was markedly higher in patients receiving dialysis (59,81); hemodialysis efficiently removed TMAO from blood (8).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] source
Not checked in the free run.
- Premisecitation
The Nurses' Health Study found women with higher fish intake had lower CVD risk than those who rarely ate fish.
“The Nurses' Health Study compared women who rarely ate fish (<1 per month) with those who ate fish regularly and found that those with a higher intake of fish had a lower risk of CVD (54).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [54] source
Not checked in the free run.
- Premisecitation
Acute intraperitoneal TMAO administration to LDLR-/- mice recapitulated the inflammatory phenotype.
“Acute intraperitoneal administration of TMAO to LDLR -/-mice recapitulated this phenotype, which could be a mechanism for development of atherosclerosis (52).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Herlaar E, 1999, Trends Mol. Med.
Not checked in the free run.
- Premisecitation
In 521 stable kidney disease patients, fasting plasma TMAO was associated with all-cause mortality.
“In a study of stable patients with kidney disease (n = 521), there was an association between fasting plasma TMAO concentrations and all-cause mortality (109).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [109] source
Not checked in the free run.
- Premisecitation
In 179 CKD stage 3-5 patients, GFR and impaired renal function were the main variables affecting plasma TMAO.
“In 179 CKD stage 3-5 patients, the GFR and impaired renal function were the main variables affecting plasma TMAO concentrations (81).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [81] source
Not checked in the free run.
- Premisecitation
The major difference between the Apo E-knockout mouse model and humans is that plaque rupture is not observed.
“The major difference between this mouse model and humans is that plaque rupture is not observed (57).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Jawien J, 2004, J. Physiol. Pharmacol.
Not checked in the free run.
- Premisecitation
Short-term TMAO treatment of primary mouse peritoneal macrophages did not cause phosphorylation of p38 MAPK, ERK1/2, or p65 NF-κB.
“Short-term TMAO treatment of primary mouse peritoneal macrophages did not result in phosphorylation of p38 mitogen-activated protein kinase, ERK1/2, and p65 NF-κB (other inflammatory pathways associated with atherosclerosis) (52).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] Herlaar E, 1999, Trends Mol. Med.
Not checked in the free run.
- Interpretationreasoning
Clinical and epidemiological data do not prove that TMAO causes heart disease.
“The clinical and epidemiological data themselves do not prove that TMAO causes heart disease.”
Quote in the paperSubstantial claim - Interpretationreasoning
The high dietary choline and/or TMAO levels used in mouse studies make direct extrapolation to humans difficult.
“Although these studies provide interesting insights to TMAO and CVD risks, the excessively high levels of dietary choline and/or TMAO used in the above studies make it difficult to extrapolate these results directly to humans.”
Quote in the paperSubstantial claim - Premisecitation
Initial observational studies of Greenland Eskimos, Alaskan natives, and Japanese Okinawa islanders reported lower coronary artery disease death risk due to higher dietary fish intake.
“Initial observational studies, involving Greenland Eskimos, Alaskan natives, and Japanese Okinawa islanders, reported lower risk of coronary artery disease death in these populations due to higher dietary fish intake (10,40,65).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
When mice were fed a chemically defined diet with 0.12% TMAO or 1% choline, ADP-induced platelet aggregation was significantly increased.
“In addition, when mice were fed a chemically defined diet supplemented with either 0.12% TMAO or 1% choline, platelet aggregation induced by adenosine diphosphate stimulation was significantly increased (136).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [136] source
Not checked in the free run.
- Premisecitation
LIRKO mice are susceptible to atherosclerosis.
“They are also susceptible to atherosclerosis (15).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] source
Not checked in the free run.
- Premisecitation
Diabetic patients treated with metformin had decreased glucose but increased plasma TMAO compared with untreated individuals.
“By contrast, patients with diabetes treated with metformin had decreased glucose but increased plasma TMAO concentrations compared with untreated individuals (55).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [55] source
Not checked in the free run.
- Premisecitation
In 123 of 1,434 Framingham participants without CKD at baseline who developed CKD over eight years, TMAO was associated with incident CKD after adjustment for GFR, sex, diabetes, hypertension, and proteinuria.
“In 123 individuals (out of 1,434 participants) in the Framingham Heart Study who did not have CKD at baseline but developed it during eight years of follow-up, metabolomic profiling on plasma showed that TMAO was associated with incident CKD even after adjustment for GFR, sex, diabetes, hypertension, and proteinuria at baseline (93).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [93] source
Not checked in the free run.
- Interpretationreasoning
These mouse data support the hypothesis that TMAO causes kidney damage in mice.
“These data support the hypothesis that, in mice, TMAO is a cause of kidney damage.”
Quote in the paperSubstantial claim - Premisenone given
Specific products that remove TMAO remain undiscovered.
“At this time, specific products that remove TMAO remain undiscovered.”
Quote in the paperNot a substantial claim - Interpretationnone given
There is evidence that feeding TMAO increases insulin resistance in animal models.
“In addition, there is evidence that feeding TMAO increases insulin resistance in animal models.”
Quote in the paperNot a substantial claim - Premisecitation
In a genome-wide analysis, TMAO was genetically associated with colorectal cancer.
“Also in a genome-wide analysis study, TMAO was genetically associated with colorectal cancer (124).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [124] source
Not checked in the free run.
- Premisecitation
Plasma TMAO significantly increased after 28 days of a low glycemic load diet.
“Plasma TMAO concentrations also were significantly increased after consumption of a low glycemic load diet for 28 days (11).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] source
Not checked in the free run.
- Premisecitation
In the Comprehensive Dialysis Study (235 ESRD patients on hemodialysis or peritoneal dialysis), no relationship was observed between serum TMAO and all-cause mortality or cardiovascular outcomes.
“For example, no relationship was observed between serum TMAO concentrations and all-cause mortality or cardiovascular outcomes in the Comprehensive Dialysis Study, a prospective cohort of 235 patients with end-stage renal disease requiring hemodialysis or peritoneal dialysis (59).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [59] source
Not checked in the free run.
- Premisecitation
In high-fat-fed 129S6 mice, serum and urinary methylamines including TMAO were associated with development of nonalcoholic fatty liver and impaired glucose metabolism.
“Serum and urinary concentrations of methylamines including TMAO were associated with the development of nonalcoholic fatty liver and impairment of glucose metabolism in high-fat-fed 129S6 mice (39).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [39] source
Not checked in the free run.
- Premisecitation
In diabetic patients, increased plasma TMAO was associated with death, myocardial infarction, heart failure, unstable angina, and other cardiovascular events.
“In diabetic patients, increased plasma TMAO concentrations were associated with death, myocardial infarction, heart failure, unstable angina, and other cardiovascular events (69).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [69] source
Not checked in the free run.
- Premisecitation
3,3-dimethyl-1-butanol, a nontoxic choline analog, inhibited conversion of choline, carnitine, and crotonobetaine, but not γ-butyrobetaine, to TMA.
“A nontoxic structural analog of choline, 3,3-dimethyl-1-butanol, inhibited the conversion of choline, carnitine, and crotonobetaine (but not γ-butyrobetaine) to TMA (119).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [119] source
Not checked in the free run.
- Interpretationnone given
There is some evidence that high plasma TMAO is correlated with diabetes risk.
“As for TMAO and CVD or renal disease, there is some evidence that high plasma TMAO concentrations are correlated with diabetes risk.”
Quote in the paperNot a substantial claim - Premisecitation
Hepatic TMAO concentrations are decreased, not increased, in diabetic db/db mice.
“It is interesting that hepatic TMAO concentrations are decreased (not increased) in diabetic db/db mice (123).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [123] source
Not checked in the free run.
- Premisecitation
An NMR-based metabolomics study found urinary TMAO associated with tubulointerstitial lesions in 77 glomerulonephritis patients.
“An NMR-based metabolomics study observed an association between urinary TMAO concentrations and tubulointerstitial lesions in patients (n = 77) with glomerulonephritis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] source
Not checked in the free run.
- Premisecitation
In individuals undergoing elective coronary angiography, plasma TMAO correlated with increased serum glucose and diabetic state.
“In individuals undergoing elective coronary angiography, plasma TMAO concentrations were correlated with increased serum glucose and the patient's diabetic state (110).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [110] source
Not checked in the free run.
- Premisenone given
The bacterial gene cluster encoding enzymes for anaerobic production of TMA from choline has been identified.
“The bacterial gene cluster that encodes the enzymes for the anaerobic production of TMA from choline have been identified (see Section 2.1).”
Quote in the paperSubstantial claim - Premisecitation
Antibiotic treatment suppresses both good and bad bacteria, making a desired impact difficult.
“Antibiotic treatment also suppresses both good and bad bacteria, making it difficult to produce a desired impact (20).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] source
Not checked in the free run.
- Premisecitation
When mice were fed these diets for 16 weeks, serum cystatin C rose.
“When mice were fed these diets for 16 weeks, serum cystatin C concentrations rose (a marker of kidney injury) (109).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [109] source
Not checked in the free run.
- Premisecitation
Alterations in TMAO metabolism have been linked to diabetes and insulin resistance.
“Alterations in TMAO metabolism have been linked to diabetes and insulin resistance.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Because renal clearance determines plasma TMAO, kidney function and TMAO must be correlated even if TMAO does not cause kidney damage.
“Because renal clearance is a determinant of plasma TMAO concentrations, kidney function and TMAO must be correlated even if TMAO does not cause kidney damage.”
Quote in the paperSubstantial claim- Rests on an assumption: Renal clearance determines plasma TMAO concentrations.
- Interpretationcitation
The mouse study in Section 5.2.2 is the most compelling evidence that TMAO and choline cause renal disease.
“The data from the mouse study discussed in Section 5.2.2 (109) are the most compelling evidence that TMAO (and choline a precursor of TMAO) causes renal disease.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [109] source
Not checked in the free run.
- Premisecitation
Serum TMAO predicted insulin resistance in cholesterol and high-fat-fed Macaca mulatta.
“Serum TMAO concentrations were also predictors of insulin resistance in cholesterol and high-fat-fed Macaca mulatta (70).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [70] source
Not checked in the free run.
- Premisecitation
The Women's Health Initiative and ATBC studies reported that alterations in choline metabolism and plasma TMAO predicted risk factors for colorectal cancer.
“The Women's Health Initiative and the alpha-tocopherol, beta-carotene cancer prevention observational studies reported that alterations in choline metabolism and plasma TMAO concentrations were predicted risk factors for colorectal cancer (7,83).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
LIRKO mice have increased expression of gluconeogenic genes due to increased FoxO1.
“LIRKO mice have increased expression of gluconeogenic genes owing to increased expression of the transcription factor forkhead box O1 (FoxO1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [77] source
Not checked in the free run.
- Premisenone given
That mouse study has not been replicated.
“This study has not been replicated, yet the paper mentions a companion study using Apo e -/-mice but fails to present its results.”
Quote in the paperSubstantial claim - Interpretationreasoning
An association between TMAO and renal disease is not sufficient evidence that TMAO causes renal disease.
“However, such an association is not sufficient evidence that TMAO causes renal disease.”
Quote in the paperSubstantial claim - Premisecitation
Transcriptional and metabolomics profiling revealed upregulation of FMO3 and its metabolite TMAO in LIRKO mice.
“Transcriptional and metabolomics profiling revealed upregulation of FMO3 and its corresponding metabolite TMAO in LIRKO mice (77).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [77] source
Not checked in the free run.
- Premisecitation
Even among patients without severe kidney disease, elevated plasma TMAO indicated poor prognosis.
“Even among patients who did not have severe kidney disease, elevated plasma TMAO concentrations indicated poor prognosis (109).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [109] source
Not checked in the free run.
- Premisecitation
In 191 patients undergoing coronary intervention, plasma TMAO was independently associated with age, diabetes, and body mass index.
“In a group of 191 patients undergoing coronary intervention, plasma TMAO concentrations were independently associated with the patients' age, diabetes, and body mass index (35).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [35] source
Not checked in the free run.
- Premisecitation
Meldonium decreased intestinal microbial-dependent production of TMAO from L-carnitine.
“It also decreased intestinal microbial-dependent production of TMAO from L-carnitine (36,67).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Meldonium decreased plasma TMAO by increasing urinary excretion in humans.
“Meldonium, a drug that has cardioprotective action, decreased plasma concentrations of TMAO by increasing urinary excretion in humans.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Resveratrol reduced plasma TMAO in Apoe-/- mice by inhibiting TMA production from gut microbiota.
“Resveratrol, a natural phytoalexin, also reduced plasma TMAO concentrations in Apo e -/-mice by inhibiting TMA production from gut microbiota (27).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] source
Not checked in the free run.
- May combine two claims. 78
- Classified as probably not a substantial claim. 31
May combine two claims.
Premisenone givenMost TMA is absorbed passively into the portal circulation and is efficiently oxidized to TMAO by hepatic FMOs.
“Most of the TMA produced is passively absorbed into portal circulation, and hepatic flavindependent monooxygenases (FMOs) efficiently oxidize TMA to TMAO.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationTMAO is biologically active and has been proposed as a contributor to chronic human diseases such as atherosclerosis.
“Trimethylamine N-oxide (TMAO) is a biologically active molecule and is a putative promoter of chronic diseases including atherosclerosis in humans.”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSome healthy women have modest trimethylaminuria at the onset of and during menstruation that then disappears.
“In some normal healthy women, modest trimethylaminuria occurs just at the onset of and during menstruation and then disappears (82).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [82] Mitchell SC, 2001, Drug Metab. Dispos.
Not checked in the free run.
May combine two claims.
PremisecitationAfter 300 g/day of cooked brussels sprouts for three weeks, people had significant increases in urinary TMA/TMAO ratio, suggesting reduced TMA N oxidation.
“After 300 g/day of cooked brussels sprouts for three weeks, people eating brussels sprouts showed significant increases in their urinary TMA/TMAO ratio, suggesting a decrease in TMA N oxidation (24).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] source
Not checked in the free run.
May combine two claims.
PremisecitationTMA can be used for methanogenesis in the gastrointestinal tract, and this pathway is active in human intestine bacteria including Methanomassiliicoccus, Methanomethylophilus, Methanobrevibacter smithii, and Methanosphaera stadtmanae.
“TMA can be used for methanogenesis in the gastrointestinal tract; in human intestine, this pathway is active in bacteria belonging to the genera Methanomassiliicoccus and Methanomethylophilus (18,21,38) as well as in Methanobrevibacter smithii and Methanosphaera stadtmanae (41).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisereasoningHuman FMO3 mutations that cause TMA excretion in sweat and breath manifest as fish-odor syndrome, or trimethylaminuria.
“Thus, mutations in FMO3 in humans that result in excretion of TMA in sweat and breath present as fish-odor syndrome (trimethylaminuria).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationA genomewide association study found no significant host genetic influences on circulating TMAO and proposed that diet and gut microbes may be the main determinants of circulating TMAO.
“Although FMO3 and FMO1 genes are important in the formation of TMAO, a genomewide association study failed to find any significant host genetic influences on circulating TMAO concentrations and proposed that dietary factors and gut microbes may be the major determinants of circulating TMAO concentrations (49).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [49] source
Not checked in the free run.
May combine two claims.
PremisecitationIn patients with renal dysfunction, circulating TMAO rises as kidney function falls, and abnormally high TMAO resolves after kidney transplantation.
“The circulating TMAO concentrations of patients with renal dysfunction increased as kidney function decreased, and abnormally high TMAO concentrations resolved after kidney transplantation (106)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [106] source
Not checked in the free run.
May combine two claims.
PremisecitationFMO3 expression in liver changes across development: mRNA and protein appear in 30% of first-trimester fetal livers, are absent in second and third trimesters, reappear by 21 postnatal days, and rise to 8% of adult levels at about 9 months, 20% by 11 years, and adult levels only after 18 years.
“Both mRNA and protein were found in 30% of fetal livers in the first trimester of pregnancy but not in the second and third trimesters; however, they could be detected again by 21 postnatal days.Expression of FMO3 then gradually increased to 8% of adult levels at about age nine months, 20% by 11 years, and did not reach adult levels until after 18 years (64, 133).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationSome microbial metabolism that produces TMA remains undiscovered.
“The elucidation of microbial TMA-generating pathways is ongoing, and it is likely that part of TMAproducing microbial metabolism remains undiscovered (41).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] source
Not checked in the free run.
May combine two claims.
PremisecitationMost TMA is absorbed into the hepatic portal circulation by passive diffusion across enterocyte membranes and is efficiently converted to TMAO by hepatic FMO1 and FMO3.
“Most TMA is absorbed into the hepatic portal circulation by passive diffusion across the enterocyte membranes and then is efficiently converted to TMAO by hepatic FMO1 and FMO3 (13); about 95% of TMA is oxidized as it is subsequently excreted in urine in a 3:95 TMA:TMAO ratio (132).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [13] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenMost trimethylaminuria cases follow autosomal recessive inheritance.
“most cases of trimethylaminuria are inherited in an autosomal recessive pattern.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
InterpretationreasoningWhether higher TMAO concentrations cause or result from these diseases is debated.
“Therefore, it is debated whether increased TMAO concentrations are the cause or result of these diseases.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFMO3 also accepts pharmaceutical substrates including cimetidine, chlorpromazine, ketoconazole, morphine, propranolol, ranitidine, sulindac, tamoxifen, and tyramine.
“In addition to TMA, other substrates for FMO3 include the pharmaceutical drugs cimetidine, chlorpromazine, ketoconazole, morphine, propranolol, ranitidine, sulindac, tamoxifen and tyramine (71).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [71] Mackay RJ, 2011, Clin. Biochem. Rev.
Not checked in the free run.
May combine two claims.
PremisecitationOrthologs and homologs of CntA/CntB and YeaW/YeaX occur in diverse gut microbiota, including Gammaproteobacteria, Betaproteobacteria, Firmicutes, and Actinobacteria, and appear absent in Bacteroidetes.
“Orthologs and homologs of the CntA/CntB and YeaW/YeaX gene pairs are found in a variety of gut microbiota: Gammaproteobacteria (Klebsiella pneumoniae, E. coli, Citrobacter, Providencia, and Shigella), Betaproteobacteria (Achromobacter), Firmicutes (Sporosarcina), and Actinobacteria; they appear to be absent in Bacteroidetes (41).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCarriers of an FMO3 mutation may have mild trimethylaminuria symptoms or temporary fish-like body odor episodes.
“Carriers of an FMO3 mutation may have mild symptoms of trimethylaminuria or experience temporary episodes of fish-like body odor (71).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [71] Mackay RJ, 2011, Clin. Biochem. Rev.
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSmall amounts of FMO1 mRNA are present in the adult small intestine.
“Small amounts of FMO1 mRNA are also found in the adult small intestine (71).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [71] Mackay RJ, 2011, Clin. Biochem. Rev.
Not checked in the free run.
May combine two claims.
Premisenone givenTMAO is a small molecule of 75.1 Da and is readily filtered by the kidneys.
“TMAO is a small molecule (75.1 Da) and is readily filtered by the kidneys.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTestosterone suppresses FMO3 expression and estrogen induces it.
“Testosterone suppresses and estrogen induces FMO3 expression.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationFMO3 activity is 100 times higher in female than male mice, while human sex-related differences are more modest.
“Thus, FMO3 activity is 100 times higher in female than in male mice; more modest gender-related differences are observed in humans (13).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] source
Not checked in the free run.
May combine two claims.
PremisecitationAfter radiolabeled TMA or TMAO is given to people, 94.5% of the dose label is excreted in urine within 24 h, 4% in feces, and less than 1% in breath.
“After administration of radiolabeled TMA or TMAO to people, 94.5% of the dose label was excreted in the urine within 24 h; only 4% of the dose was excreted in the feces and <1% in the breath (2).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] source
Not checked in the free run.
May combine two claims.
Premisenone givenIn the chicken nephron, TMAO is passively excreted in proximal tubules via a probenecid-sensitive luminal transporter, while TMA N-oxidation uses a quinidine-sensitive basal transporter.
“It is passively excreted in the proximal tubules of the chicken nephron via a probenecid-sensitive transporter at the luminal side, whereas N-oxidation of TMA occurs via a quinidine-sensitive transporter at the basal side.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTMAO may worsen several chronic diseases, including atherosclerosis, diabetes, and chronic kidney disease.
“it may exacerbate several chronic diseases including atherosclerosis, diabetes, and chronic kidney diseases (20).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn Britain, the estimated incidence of carrier status for trimethylaminuria is 1%.
“In Britain, it is estimated that the incidence of carrier status for trimethylaminuria is 1% (82)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [82] Mitchell SC, 2001, Drug Metab. Dispos.
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenMore than 300 variants or single-nucleotide polymorphisms have been reported in FMO3.
“More than 300 variants or single-nucleotide polymorphisms have been reported in FMO3.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationFMO1 mRNA and protein are expressed in human liver in the first trimester, decline in the second and third trimesters, and disappear by about the third postnatal day in liver and kidney.
“FMO1 mRNA and protein are expressed in the human liver during the first trimester, declining gradually in the second and third trimesters, and disappearing completely by about the third postnatal day in the liver and kidney (71).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [71] Mackay RJ, 2011, Clin. Biochem. Rev.
Not checked in the free run.
May combine two claims.
PremisecitationColonizing gnotobiotic mice with choline-converting bacteria raises cecal TMA production and lowers serum choline.
“Colonization of gnotobiotic mice with choline-converting bacteria not only increases cecal TMA production but also lowers serum choline concentration (96).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [96] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe adequate choline intake is 550 mg/day for men and 425 mg/day for women, adjusted upward in pregnancy and lactation; the upper limit ranges from 1,000 mg/day in children to 3,500 mg/day in adults.
“The adequate intake is 550 mg/day for men and 425 mg/day for women, with upward adjustment in pregnant and lactating women; the upper intake limit ranges from 1,000 mg/day in children to 3,500 mg/day in adults (56).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] Inst. Med., Natl. Acad., 1998
Not checked in the free run.
May combine two claims.
PremisecitationCholine occurs in foods as free choline and choline esters, and these forms are absorbed differently in the intestine.
“Choline is present as free choline and choline esters (such as PtdCho) in foods (130), and these forms of choline are absorbed differently in the intestines.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [130] source
Not checked in the free run.
May combine two claims.
PremisecitationIn a small study of healthy Bavarian subjects, fish, meat, or egg intake was not associated with plasma TMAO, but dairy intake was positively associated with plasma TMAO.
“In a small study in healthy Bavarian subjects, dietary intake of fish, meat, or eggs was not associated with plasma TMAO concentrations, but dairy intake was positively associated with plasma TMAO concentrations (94).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [94] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation100 g of spinach contains 577 mg betaine, 100 g of cod or beef contains 7 mg betaine, and 100 g of eggs contains less than 1 mg betaine.
“For example, 100 g of spinach contains 577 mg betaine, 100 g of cod or beef contain 7 mg betaine, and 100 g of eggs contain <1 mg betaine.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn 1998, the US Institute of Medicine set adequate intake and tolerable upper intake values for choline based on limited human studies.
“In 1998, the US Institute of Medicine (Food and Nutrition Board) established adequate intake and tolerable upper intake limit values for choline, based on limited human studies (56).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] Inst. Med., Natl. Acad., 1998
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationTMA is formed in male ejaculate and vaginal secretions, TMA formation may be regulated by sex hormones, and cycle-dependent TMA variations occur in women.
“TMA is formed in male ejaculate and vaginal secretions, and as noted in Section 2.2, TMA formation may be regulated by sex hormones (13), and cycle-dependent variations in TMA occur in women (82).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [13] source
Not checked in the free run.
- cites [82] Mitchell SC, 2001, Drug Metab. Dispos.
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe foods richest in betaine are plant foods, especially spinach, beets, and grains grown in high-osmotic environments.
“The foods that contain the most betaine are of plant origin, especially spinach, beets and grains grown in high osmotic environments (129, 130).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationL-carnitine bioavailability is higher in vegetarians than in carnivores, so less carnitine reaches lower-intestine bacteria in vegetarians.
“The bioavailability of L-carnitine in vegetarians (who are adapted to low-carnitine diets) was higher than in carnivores (42); therefore, less carnitine reaches the bacteria of the lower intestine in vegetarians.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [42] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation100 g of cod contains 89 mg total choline, 100 g of beef contains 73 mg, and 100 g of eggs contains 266 mg total choline.
“For example, 100 g of cod contains 89 mg total choline (choline + PtdCho + phosphocholine + sphingomyelin + glycerophosphocholine) compared to 100 g of beef, which contains 73 mg total choline, or 100 g of eggs, which contain 266 mg total choline (28).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28] source
Not checked in the free run.
May combine two claims.
Premisecitation100 g of cod contains 300 mg TMAO, whereas 100 g of beef or egg contains less than 1 mg TMAO.
“For example, 100 g of cod contains 300 mg TMAO compared to 100 g of beef or of egg, which contain <1 mg TMAO (28).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28] source
Not checked in the free run.
May combine two claims.
PremisecitationTAAR5 is the most highly expressed TAAR gene in humans and may act as an olfactory detector of TMA that elicits innate behaviors.
“TAAR5 is the most highly expressed TAAR gene in humans and may constitute an olfactory detector of TMA that elicits innate behaviors (117).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [117] source
Not checked in the free run.
May combine two claims.
PremisecitationTMAO production after an L-carnitine challenge was significantly greater in omnivores than vegans, and specific bacterial taxa were associated with dietary status and plasma TMAO.
“TMAO production, following a challenge with L-carnitine, was significantly greater in omnivores versus vegans, and there were specific bacterial taxa associated with both dietary status and plasma TMAO concentration (63).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [63] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPlants use betaine in their roots as an osmolyte to help retain intracellular water.
“Plants use betaine in their roots as an osmolyte to help them retain intracellular water (33).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] source
Not checked in the free run.
May combine two claims.
PremisecitationTMAO and TMA are present at high concentrations in fish and other seafood, with marine fish having higher concentrations than freshwater fish.
“TMAO and TMA are present in high concentrations in fish and other seafood.Marine fish (e.g., cod, haddock, halibut, herring, skate) have higher concentrations than do freshwater fish (e.g., trout) (9).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] source
Not checked in the free run.
May combine two claims.
PremisecitationAnimal products such as meat, fish, poultry, and milk are highest in carnitine, while plants contain little carnitine.
“Animal products like meat, fish, poultry, and milk (whey fraction) are highest in carnitine, whereas plants contain little carnitine (42).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] source
Not checked in the free run.
May combine two claims.
PremisecitationAbout 15% of egg PtdCho was converted to TMA, and peak plasma TMA occurred 6 to 8 h after egg ingestion.
“About 15% of the PtdCho in eggs was converted to TMA, and peak plasma TMA concentrations were achieved between 6 and 8 h after ingestion of the eggs (79).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [79] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe foods richest in choline are animal foods, especially eggs and liver, but most foods eaten contain some choline or choline compounds.
“The foods that contain the most choline are of animal origin, especially eggs and liver; however, most of the foods we eat contain some amounts of choline or choline compounds (129, 130).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
Premisecitation100 g of asparagus contains 0.2 mg carnitine, 100 g of egg contains less than 1 mg, 100 g of cod contains 4 mg, and 100 g of beef contains 39 mg carnitine.
“For example, 100 g of asparagus contains 0.2 mg carnitine, 100 g of egg contains <1 mg carnitine, 100 g of cod contains 4 mg carnitine while 100 g of beef contains 39 mg carnitine, (28).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28] source
Not checked in the free run.
May combine two claims.
PremisecitationTMAO is a tissue osmolyte and a molecular chaperone that stabilizes proteins.
“TMAO is an osmolyte in tissues and acts as a molecular chaperone that stabilizes proteins.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationCholine is absorbed in the small intestine by mediated transport, whereas PtdCho is absorbed intact through lymph or hydrolyzed by pancreatic lipases and absorbed as glycerophosphocholine.
“Choline is absorbed in the small intestine via mediated transport, whereas PtdCho is absorbed intact via the lymphatic system or is hydrolyzed by pancreatic lipases and absorbed as glycerophosphocholine (125).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [125] source
Not checked in the free run.
May combine two claims.
PremisecitationTMAO preserves the folded state of proteins and counteracts denaturants such as pH, urea, and high pressure.
“It retains the folded state of proteins and counteracts the effect of denaturants, such as pH, urea, and high pressure (6,13,29).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationHuman TAAR5 is selectively activated by TMA in a concentration-dependent manner but not by TMAO.
“Human TAAR5 can be selectively activated in a concentrationdependent manner by TMA but not by TMAO (117).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [117] source
Not checked in the free run.
May combine two claims.
PremisecitationHigh circulating TMAO increases cholesterol influx into peritoneal macrophages, while cholesterol efflux or biosynthesis appears unchanged.
“Even though high concentrations of circulating plasma TMAO increase cholesterol influx to peritoneal macrophages (118), cholesterol efflux or cholesterol biosynthesis appears to be unchanged.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [118] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationTrace amine-associated receptors are G protein-coupled receptors and olfactory receptors.
“Trace amine-associated receptors (TAARs) belong to the family of G protein-coupled receptors and are olfactory receptors (117).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [117] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCarnitine can be synthesized endogenously from lysine and methionine in kidney, liver, and brain.
“Carnitine also can be synthesized endogenously from two essential amino acids, lysine and methionine (63).This occurs in kidney, liver, and brain (42).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
InterpretationreasoningThese processes appear to be regulated by TMA or by other unidentified enzymatic substrates or products of FMO3.
“Rather, these processes appear to be regulated by either TMA or other unidentified enzymatic substrates or products of FMO3.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAntibiotics eliminated the FMO3 substrate TMA and normalized intestinal cholesterol absorption and fecal neutral sterol loss in FMO3 antisense oligonucleotide-treated mice.
“The administration of antibiotics eliminated the FMO3 substrate TMA and normalized intestinal cholesterol absorption and fecal neutral sterol loss seen in FMO3 antisense oligonucleotide-treated mice (121).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [121] source
Not checked in the free run.
May combine two claims.
Premiseown dataIn both clinical cohorts, kidney function was not normal; mean GFRs were 73 and 74 mL/min (range 60-87), compatible with some loss of kidney function.
“In both the clinical cohorts, kidney function was not normal [normal glomerular filtration rate (GFR) is ∼100 mL/min]; the mean GFRs in both groups were 73 and 74 mL/min, respectively (range 60-87), values compatible with some loss of kidney function.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationDietary TMAO supplementation decreased intestinal cholesterol absorption, consistent with reduced Niemann-Pick C1-like 1 expression.
“Dietary supplementation of TMAO also decreased intestinal cholesterol absorption.The effect is consistent with reduced expression of the cholesterol transporter Niemann-Pick C1-like 1 but again does not explain reductions in RCT (118).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [118] source
Not checked in the free run.
May combine two claims.
Premisenone givenPeople at risk for cardiovascular disease and stroke have high plasma TMAO and higher plasma concentrations of the TMAO precursors choline, betaine, and carnitine.
“People at risk for CVD and stroke have high plasma TMAO concentrations; they also have higher concentrations of the TMAO precursors, i.e., choline, betaine, and carnitine in plasma.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationFMO3 knockdown in C57Bl/6 female mice greatly reduced hepatic FMO3 expression, increased plasma TMA, and reduced TMAO.
“When C57Bl/6 female mice were fed either a low-or high-cholesterol diet, FMO3 knockdown greatly reduced hepatic FMO3 expression with corresponding increases in plasma TMA concentrations and reductions in TMAO concentrations (121).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [121] source
Not checked in the free run.
May combine two claims.
PremisecitationFMO3 inhibition stimulated fecal neutral sterol loss and basal and liver X receptor-dependent macrophage reverse cholesterol transport.
“FMO3 inhibition stimulated fecal neutral sterol loss and basal and liver X receptor-dependent macrophage RCT (121).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [121] source
Not checked in the free run.
May combine two claims.
InterpretationreasoningBoth studies conclude that FMO3 inhibition has positive effects on cholesterol and glucose homeostasis and that TMAO does not appear to be a critical player.
“Thus, both studies conclude that FMO3 inhibition has definite positive effects on cholesterol and glucose homeostasis and that TMAO does not seem to be a critical player.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationThat study concluded plasma TMAO was confounded by impaired kidney function because it increased with declining GFR.
“The study concluded that plasma concentrations of TMAO were confounded by impaired kidney function because it was increased with declining GFR (85).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [85] source
Not checked in the free run.
May combine two claims.
PremisecitationFMO3 knockdown altered intestinal cholesterol absorption, hepatic cholesterol ester storage, and macrophage reverse cholesterol transport in a dietary cholesterol-dependent manner.
“FMO3 knockdown altered several steps of cholesterol balance, including intestinal cholesterol absorption, hepatic cholesterol ester storage, and macrophage RCT in a dietary cholesterol-dependent manner (121).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [121] source
Not checked in the free run.
May combine two claims.
Premisenone givenMouse peritoneal macrophages incubated with TMA express scavenger receptors, accumulate cholesterol, and form foam cells.
“Mouse peritoneal macrophages incubated with TMA express scavenger receptors, accumulate cholesterol, and form foam cells.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe choline doses used in that mouse heart failure study were twelve times higher than normal mouse diet choline and were not physiologic.
“Interpretation of such results is difficult, as normal mouse diets contain 0.1% choline, and the authors treated mice with amounts of choline twelve times higher; these levels are not physiologic.”
Quote in the paperSubstantial claim- Rests on an assumption: Normal mouse diets contain 0.1% choline.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThis cohort had a mean eGFR of 83 mL/min.
“This cohort had a mean eGFR of 83 mL/min (63).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [63] source
Not checked in the free run.
May combine two claims.
PremisecitationTMAO feeding did not change hepatic cholesterol exporter expression, but it caused striking reductions in bile acid pool size and species and reduced expression of Cyp7a1 and Cyp27a1.
“TMAO feeding did not change the expression of hepatic cholesterol exporters, but striking reductions in bile acid pool size and species, along with reduced expression of the cytochrome P450 family of enzymes, Cyp7a1 and Cyp27a1, were noted (118).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [118] source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThese results suggest that although chronic TMAO elevation can be harmful in mice, FMO3's ability to reorganize cholesterol balance is most likely not mediated through TMAO.
“These results suggest that, although chronic elevation of TMAO can be detrimental in mice, the ability of FMO3 to reorganize cholesterol balance is most likely not mediated through TMAO.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningTaken together, the results provide evidence that TMAO alters cholesterol elimination pathways and causes reductions in reverse cholesterol transport.
“Taken together these results provide evidence that TMAO alters pathways for cholesterol elimination from the body and causes reductions in RCT.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationHumans carry about 75% of plasma cholesterol in LDL particles, while mice carry most cholesterol in HDL particles.
“Humans carry about 75% of their plasma cholesterol in low-density lipoprotein (LDL) particles, whereas mice carry most of their cholesterol in high-density lipoprotein (HDL) particles (57).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Jawien J, 2004, J. Physiol. Pharmacol.
Not checked in the free run.
May combine two claims.
Interpretationnone givenThere are strong data suggesting an association between TMAO and CVD risk, but equally strong inconsistencies.
“Thus, there are strong data that suggest an association between TMAO and CVD risk, but there are equally strong inconsistencies.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationA meta-analysis of 11 studies and 13 cohorts (n=222,364) found fish consumption inversely associated with CVD and possibly reduced CVD mortality.
“A meta-analysis of 11 eligible studies and 13 cohorts (n = 222,364) found that fish consumption was inversely associated with CVD and may even reduce mortality due to CVD (50,51).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
InterpretationreasoningExisting mouse data may support the hypothesis that TMAO causes atherosclerosis, but extrapolation from a particular mouse model to humans should be cautious.
“Thus, the existing mouse data may support the hypothesis that TMAO causes atherosclerosis, but given the concerns discussed above, we should be cautious about extrapolating data from a particular mouse model to humans.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationChronic choline supplementation of LDLR-/- mice increased plasma TMAO and increased expression of inflammatory genes in vascular cells.
“Chronic choline supplementation of atherosclerosis-prone low-density lipoprotein receptor (LDLR -/-) mice increased plasma TMAO concentrations and increased expression of inflammatory genes in vascular cells (52).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Herlaar E, 1999, Trends Mol. Med.
Not checked in the free run.
May combine two claims.
PremisecitationUremia accelerates atherosclerosis and arterial calcification in patients with chronic renal failure.
“Uremia accelerates atherosclerosis and arterial calcification in patients with chronic renal failure (22,74).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationApo E-knockout mice have a shift in plasma lipoproteins from HDL to cholesterol-enriched remnants of chylomicrons and VLDLs, and phenotypes similar to Apo E-deficient humans.
“Apo E-knockout mice have a shift in plasma lipoproteins from HDL, the major lipoprotein in wild-type mice, to cholesterolenriched remnants of chylomicrons and VLDLs, and these mice have phenotypes similar to those of Apo E-deficient humans (57).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Jawien J, 2004, J. Physiol. Pharmacol.
Not checked in the free run.
May combine two claims.
PremisecitationSerum TMAO was inversely associated with eGFR and markedly higher in dialysis patients.
“Serum concentration of TMAO was inversely associated with eGFR and was markedly higher in patients receiving dialysis (59,81); hemodialysis efficiently removed TMAO from blood (8).”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S4 (based).
Premisenone givenTMAO is cleared from plasma by the kidney.
“TMAO is cleared from plasma by the kidney.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningIf TMAO causes CVD, eating more fish should increase heart disease risk; it does not.
“If TMAO causes CVD, then eating more fish should be associated with increased risk for heart disease; it is not.”
Quote in the paperSubstantial claim- Rests on an assumption: Fish contain high concentrations of TMA, and gut bacteria convert this TMA to TMAO in people who eat fish.
May combine two claims.
PremisereasoningTMAO is excreted by the kidneys and is elevated in patients with kidney disease.
“As noted above in Section 2.3, TMAO is excreted by the kidneys, and this metabolite is elevated in patients with kidney disease.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThose macrophages had excess cholesterol accumulation and foam cell formation.
“These macrophages had excess cholesterol accumulation and foam cell formation (118).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [118] source
Not checked in the free run.
May combine two claims.
PremisecitationIncreased TMAO was associated with systemic inflammatory markers and predicted reduced five-year survival.
“Increased TMAO concentrations were associated with systemic inflammatory markers and predicted a reduced fiveyear survival (81).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [81] source
Not checked in the free run.
May combine two claims.
PremisecitationApo E knockout mice are considered one of the most relevant models for atherosclerosis because they are hypercholesterolemic and develop spontaneous arterial lesions.
“Apo E knockout mice are considered to be one of the most relevant models for atherosclerosis because they are hypercholesterolemic and develop spontaneous arterial lesions (87).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [87] source
Not checked in the free run.
May combine two claims.
PremisecitationTMA can be used for methanogenesis in the gastrointestinal tract, and bacteria of the genera Methanomassiliicoccus and Methanomethylophilus have this pathway.
“TMA can be used for methanogenesis in the gastrointestinal tract, and bacteria belonging to the genera Methanomassiliicoccus and Methanomethylophilus have this pathway (18,21,38,41).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationKnockdown of FMO3 in LIRKO mice suppressed FoxO1 expression and improved glucose tolerance by upregulating SREBP2.
“Knockdown of FMO3 in LIRKO mice suppressed FoxO1 expression (and improved glucose tolerance) by upregulating sterol regulatory element binding protein 2 (SREBP2) (77).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [77] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTMAO was used as a urinary marker in a mouse model of gastric tumorigenesis.
“TMAO was used also as a urinary marker in a mouse model of gastric tumorigenesis (60).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOral charcoal adsorbent AST-120 has been clinically used to remove uremic toxins such as indoxyl sulfate in advanced renal failure.
“To this end, oral charcoal adsorbent (AST-120) has been clinically used to remove uremic toxins, such as indoxyl sulfate, in patients with advanced renal failure (86).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [86] source
Not checked in the free run.
May combine two claims.
PremisecitationIn C57BL/6J mice fed high-choline or TMAO-supplemented diets for six weeks, plasma TMAO increased and was associated with increases in tubulointerstitial fibrosis, collagen deposition, and kidney injury marker-1.
“When C57BL/6J mice were fed either a high-choline diet or a diet supplemented with TMAO for six weeks, plasma concentrations of TMAO increased and were associated with corresponding increases in tubulointerstitial fibrosis and collagen deposition, as well as increases in kidney injury marker-1.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [109] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThat study concluded increased TMAO excretion could be due to tubulointerstitial distortions.
“The study concluded that this increased excretion of TMAO could be due to tubulointerstitial distortions (4).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] source
Not checked in the free run.
May combine two claims.
PremisecitationSREBP2 directly activates microRNA 182, which regulates FoxO1 expression.
“SREBP2 directly activates microRNA 182, which in turn regulates FoxO1 expression (77).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [77] source
Not checked in the free run.
May combine two claims.
PremisecitationLIRKO mice cannot respond to insulin in the liver and display features of diabetes such as hyperglycemia, hyperinsulinemia, and dyslipidemia.
“Liver insulin receptor knockout (LIRKO) mice are unable to respond to insulin in the liver and display several features of diabetes, such as hyperglycemia, hyperinsulinemia, and dyslipidemia.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
InterpretationreasoningExisting mouse data may support the hypothesis that TMAO causes renal disease, but extrapolation from a particular mouse model to humans should be cautious.
“Thus, the existing mouse data may support the hypothesis that TMAO causes renal disease, but given the concerns discussed in Section 5.1.4,scientists and clinicians should be cautious about extrapolating data from a particular mouse model to humans.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIntroducing Lactobacillus paracasei in mice expressing human baby flora decreased fecal choline and was associated with reduced TMA and dimethylamine in liver and plasma lipoproteins.
“Even though it needs to be demonstrated in humans, introducing Lactobacillus paracasei in mice expressing human baby flora decreased fecal choline and was associated with reduced concentrations of TMA and dimethylamine in the liver and plasma lipoproteins (73).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [73] source
Not checked in the free run.
Probably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing).
PremisecitationAccumulation of TMAO in ESRD patients on chronic hemodialysis is mainly due to a previously unrecognized limitation of chronic dialysis.
“It was suggested that the accumulation of TMAO in end-stage renal disease patients who receive chronic hemodialysis is mainly due to the previously unrecognized limitation of chronic dialysis (45).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] source
Not checked in the free run.
May combine two claims.
PremisecitationIn high-fat-fed C57Bl/6 mice, TMAO feeding increased diet-induced glucose intolerance, as measured by higher fasting insulin and HOMA-IR, along with altered insulin signaling and increased inflammatory markers.
“In high-fat-fed C57Bl/6 mice, TMAO feeding increases the glucose intolerance induced by the diet as measured by higher fasting insulin levels and the homeostasis model assessment (HOMA) for insulin resistance scores along with altered insulin signaling and increased inflammatory markers (44).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenThe investigators did not determine with antibiotics whether conversion of choline to TMAO was required for the choline effects.
“And the investigators did not determine, using antibiotics, whether conversion of choline to TMAO was required for the choline effects.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationLong-term antibiotic use can promote antibiotic-resistant bacterial strains and repopulation of microbes after withdrawal.
“However, long-term usage of antibiotics can promote the emergence of antibiotic-resistant bacterial strains and repopulation of microbes after its withdrawal.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] source
Not checked in the free run.
May combine two claims.
PremisecitationTMAO is cleared more efficiently than urea by normal kidney function but not by dialysis.
“TMAO is cleared more efficiently than urea by the normal kidney function but not by dialysis (45).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [45] source
Not checked in the free run.
May combine two claims.
Premisecitation3,3-dimethyl-1-butanol significantly lowered plasma TMAO and mitigated choline-enhanced macrophage foam cell formation and atherosclerosis in Apoe-/- mice.
“It also significantly lowered plasma TMAO concentrations and mitigated choline-enhanced macrophage foam cell formation and atherosclerosis in Apo e -/-mice (119).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [119] source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationFMOs are major xenobiotic metabolizing enzymes.
“One should also consider the side effects associated with inhibiting FMOs as they are major xenobiotic metabolizing enzymes (23).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] source
Not checked in the free run.
May combine two claims.
PremisecitationInhibiting FMO enzymes may not be ideal because it causes TMA accumulation, leading to fishy odor and inflammation as observed in antisense oligonucleotide-treated mice.
“Inhibiting FMO enzymes, however, may not be ideal as it causes accumulation of TMA, leading to a fishy odor and inflammation as observed in antisense oligonucleotide-treated mice (102, 121).”
Quote in the paperSubstantial claim0 of 2 sources checked
The paper relies on this without support.
Plasma TMAO concentration is a valid proxy for the biologically relevant TMAO exposure at target tissues.
“Both observational and experimental studies suggest a strong positive correlation between increased plasma TMAO concentrations and adverse cardiovascular events, such as myocardial infarction, stroke, and death.”
“TMAO-mediated atherosclerosis could potentially be a significant cause of heart and kidney disease, but the underlying mechanisms whereby TMAO is related to heart and kidney disease need to be fully elucidated and validated.”
The paper relies on this without support.
Fish contain high concentrations of TMA, and gut bacteria convert this TMA to TMAO in people who eat fish.
“Fish contain high concentrations of TMA, which are converted to TMAO by bacteria in the gut of people who eat fish.”
The paper relies on this without support.
Renal clearance determines plasma TMAO concentrations.
“Because renal clearance is a determinant of plasma TMAO concentrations, kidney function and TMAO must be correlated even if TMAO does not cause kidney damage.”
The paper relies on this without support.
Normal mouse diets contain 0.1% choline.
“Interpretation of such results is difficult, as normal mouse diets contain 0.1% choline, and the authors treated mice with amounts of choline twelve times higher; these levels are not physiologic.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
TMA is generated in the gut from betaine, L-carnitine and its metabolite γ-butyrobetaine, choline and other choline-containing compounds present in the diet.
“TMA is generated in the gut from betaine, L-carnitine and its metabolite γ-butyrobetaine (GBB), choline and other choline-containing compounds, which are present in the diet.”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [18]
Nearly 95% of TMA is oxidized and excreted in urine in a 3:95 TMA:TMAO ratio within 24 h; only 4% is excreted in feces and less than 1% is eliminated in breath.
“Nearly 95% of TMA is oxidized and it is afterwards excreted in urine in a 3:95 TMA: TMAO ratio within 24 h, only 4% is excreted in feces and less than 1% is eliminated in the breath [18].”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [18]
Gut bacteria are essential to transform dietary compounds into TMA in gnotobiotic mice.
“It has been demonstrated in gnotobiotic mice that gut bacteria are essential to transform the dietary compounds into TMA [18].”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [18]
FMO3 is the main enzyme responsible for conversion of TMA into TMAO because FMO1 has tenfold lower specific activity in the liver than FMO3.
“FMO1 has tenfold lower specific activity in the liver than does FMO3, so FMO3 is the main enzyme responsible for the conversion of TMA into TMAO [18].”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [18]
Oral charcoal adsorbent (AST-120) has been clinically used to remove uremic toxins such as indoxyl sulfate from patients with advanced renal failure.
“For example, oral charcoal adsorbent (AST-120) has been clinically used to remove uremic toxins such as indoxyl sulfate from patients with advanced renal failure.”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [18]
The gene cluster responsible for the conversion of choline into TMA has been identified.
“The gene cluster responsible for the conversion of choline into TMA has been identified.”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [18]
No compound that specifically removes TMAO has yet been discovered.
“However, a compound that removes specifically TMAO has not yet been discovered [18,95].”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [18]
CutC and CutD are necessary for the conversion of choline into TMA.
“CutC and CutD are necessary for that transformation; so they could be used like targets as their inhibition eradicates the production of TMA [18].”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [18]
Accumulation of TMA leads to trimethylaminuria, which is characterized by fishy odor and induces inflammation.
“Nevertheless, there could be several problems with this approach as an accumulation of TMA leads to trimethylaminuria, which is characterized by fishy odor (similar to rotten fish) and induce inflammation [18,75,99].”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [18]
TMAO is not the only substrate for FMO3; morphine, propranolol and tyramine are also metabolized by FMO3.
“Another problem would be that TMAO is not the only substrate for FMO3; morphine, propranolol and tyramine are also metabolized by FMO3 [18].”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [18]
Inhibition of CutC and CutD eradicates the production of TMA.
“CutC and CutD are necessary for that transformation; so they could be used like targets as their inhibition eradicates the production of TMA [18].”
From Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target (2018) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
The paper gives conflicting sites for conversion of TMA to TMAO
MinorThe fish discussion attributes conversion of TMA to TMAO to gut bacteria, whereas the paper's pathway description assigns that conversion to enzymes in the liver.
“Fish contain high concentrations of TMA, which are converted to TMAO by bacteria in the gut of people who eat fish.”
“This absorbed TMA is delivered to the liver where flavin-dependent monooxygenase (FMO) isoforms 1 and 3 convert it to TMAO.”
The macrophage evidence is described as a different experiment
MinorThe evidence summary says macrophages were incubated with TMA. The detailed account instead describes macrophages taken from mice fed TMAO, changing both the compound and how the cells were exposed.
“Mouse peritoneal macrophages incubated with TMA express scavenger receptors, accumulate cholesterol, and form foam cells.”
“Peritoneal macrophages obtained from C57BL/6J mice, fed a TMAO-supplemented diet for more than three weeks, showed increased mRNA levels of two macrophage scavenger receptors (CD36 and SR-A1), which are implicated in atherosclerosis (118).”
Cites
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596 · see citing works
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597 · see citing works
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386 · see citing works
Self-citationIntestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,402 · cited 4× · see citing works
“However, consumption of ≥2 eggs, which contain mostly PtdCho, results in increased formation of TMAO (79, 110).”
BackgroundResultInfluentialInstitute of Medicine (1998) · National Academies Press eBooks · doi:10.17226/6015 · Cited by 2,464 · see citing works
The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart Disease
Kromhout, D., Bosschieter, E. B., & Coulander, C. D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121901 · Cited by 2,177 · see citing works
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968 · see citing works
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.133 · Cited by 1,693 · see citing works
Wang, Z., Roberts, A. B., Buffa, J. A., Levison, B. S., Zhu, W., Org, E., Gu, X., Huang, Y., Zamanian-Daryoush, M., Culley, M. K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.055 · Cited by 1,317 · see citing works
Tang, W. H. W., Wang, Z., Kennedy, D. J., Wu, Y., Buffa, J. A., Agatisa-Boyle, B., Li, X. S., Levison, B. S., & Hazen, S. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.305360 · Cited by 1,223 · see citing works
Bennett, B. J., Vallim, T. Q. D. A., Wang, Z., Shih, D. M., Meng, Y., Gregory, J., Allayee, H., Lee, R., Graham, M., Crooke, R., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.011 · Cited by 1,070 · see citing works
Craig, S. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.3.539 · Cited by 1,062 · see citing works
Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601056103 · Cited by 1,042 · cited 1× · see citing works
“Serum and urinary concentrations of methylamines including TMAO were associated with the development of nonalcoholic fatty liver and impairment of glucose metabolism in high-fat-fed 129S6 mice (39).”
BackgroundFish and Omega-3 Fatty Acid Intake and Risk of Coronary Heart Disease in Women
Hu, F. B. (2002) · JAMA · doi:10.1001/jama.287.14.1815 · Cited by 1,018 · see citing works
Fish Consumption and Risk of Sudden Cardiac Death
Albert, C. M. (1998) · JAMA · doi:10.1001/jama.279.1.23 · Cited by 990 · see citing works
Seldin, M. M., Meng, Y., Qi, H., Zhu, W., Wang, Z., Hazen, S. L., Lusis, A. J., & Shih, D. M. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002767 · Cited by 911 · see citing works
Fatty acid composition of the plasma lipids in Greenland Eskimos
Dyerberg, J., Bang, H., & Hjørne, N. (1975) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/28.9.958 · Cited by 877 · see citing works
Romano, K. A., Vivas, E. I., Amador-Noguez, D., & Rey, F. E. (2015) · mBio · doi:10.1128/mbio.02481-14 · Cited by 777 · see citing works
He, K., Song, Y., Daviglus, M. L., Liu, K., Van Horn, L., Dyer, A. R., & Greenland, P. (2004) · Circulation · doi:10.1161/01.cir.0000132503.19410.6b · Cited by 764 · see citing works
Chen, M.-L., Yi, L., Zhang, Y., Zhou, X., Ran, L., Yang, J., Zhu, J.-D., Zhang, Q.-Y., & Mi, M.-T. (2016) · mBio · doi:10.1128/mbio.02210-15 · Cited by 754 · cited 2× · see citing works
“The proatherogenic effects of feeding choline to Apoe−/− mice was also reported by others (27).”
BackgroundConcentrations of Choline-Containing Compounds and Betaine in Common Foods
Zeisel, S. H., Mar, M.-H., Howe, J. C., & Holden, J. M. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.5.1302 · Cited by 744 · see citing works
Self-citationCholine: Critical Role During Fetal Development and Dietary Requirements in Adults
Zeisel, S. H. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111156 · Cited by 741 · see citing works
Self-citationMicrobial conversion of choline to trimethylamine requires a glycyl radical enzyme
Craciun, S., & Balskus, E. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215689109 · Cited by 701 · see citing works
PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91658-8 · Cited by 690 · see citing works
A molecular mechanism for osmolyte-induced protein stability
Street, T. O., Bolen, D. W., & Rose, G. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606236103 · Cited by 670 · see citing works
Flanagan, J. L., Simmons, P. A., Vehige, J., Willcox, M. D., & Garrett, Q. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-30 · Cited by 611 · cited 3× · see citing works
“Animal products like meat, fish, poultry, and milk (whey fraction) are highest in carnitine, whereas plants contain little carnitine (42).”
BackgroundPLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1986.tb07607.x · Cited by 604 · see citing works
Dridi, B., Fardeau, M.-L., Ollivier, B., Raoult, D., & Drancourt, M. (2012) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.033712-0 · Cited by 596 · see citing works
Wang, Z., Tang, W. H. W., Buffa, J. A., Fu, X., Britt, E. B., Koeth, R. A., Levison, B. S., Fan, Y., Wu, Y., & Hazen, S. L. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu002 · Cited by 559 · see citing works
γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO
Koeth, R. A., Levison, B. S., Culley, M. K., Buffa, J. A., Wang, Z., Gregory, J. C., Org, E., Wu, Y., Li, L., Smith, J. D., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.006 · Cited by 546 · see citing works
Biddinger, S. B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J. T., Alemán, J. O., Suzuki, R., Scapa, E. F., Agarwal, C., Carey, M. C., Stephanopoulos, G., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.013 · Cited by 469 · see citing works
Trøseid, M., Ueland, T., Hov, J. R., Svardal, A., Gregersen, I., Dahl, C. P., Aakhus, S., Gude, E., Bjørndal, B., Halvorsen, B., et al. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12328 · Cited by 464 · see citing works
Rohrmann, S., Overvad, K., Bueno-de-Mesquita, H. B., Jakobsen, M. U., Egeberg, R., Tjønneland, A., Nailler, L., Boutron-Ruault, M.-C., Clavel-Chapelon, F., Krogh, V., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-63 · Cited by 454 · see citing works
Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden
Stubbs, J. R., House, J. A., Ocque, A. J., Zhang, S., Johnson, C., Kimber, C., Schmidt, K., Gupta, A., Wetmore, J. B., Nolin, T. D., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014111063 · Cited by 450 · see citing works
The Gut Microbial Endocrine Organ: Bacterially Derived Signals Driving Cardiometabolic Diseases
Brown, J. M., & Hazen, S. L. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-060513-093205 · Cited by 438 · see citing works
Martin, F. J., Wang, Y., Sprenger, N., Yap, I. K. S., Lundstedt, T., Lek, P., Rezzi, S., Ramadan, Z., van Bladeren, P., Fay, L. B., et al. (2008) · Molecular Systems Biology · doi:10.1038/msb4100190 · Cited by 421 · see citing works
The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance
Warrier, M., Shih, D. M., Burrows, A. C., Ferguson, D., Gromovsky, A. D., Brown, A. L., Marshall, S., McDaniel, A., Schugar, R. C., Wang, Z., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.036 · Cited by 414 · see citing works
Self-citationCho, C. E., Taesuwan, S., Malysheva, O. V., Bender, E., Tulchinsky, N. F., Yan, J., Sutter, J. L., & Caudill, M. A. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600324 · Cited by 405 · see citing works
Organ, C. L., Otsuka, H., Bhushan, S., Wang, Z., Bradley, J., Trivedi, R., Polhemus, D. J., Tang, W. H. W., Wu, Y., Hazen, S. L., et al. (2016) · Circulation: Heart Failure · doi:10.1161/circheartfailure.115.002314 · Cited by 382 · see citing works
Chowdhury, R., Stevens, S., Gorman, D., Pan, A., Warnakula, S., Chowdhury, S., Ward, H., Johnson, L., Crowe, F., Hu, F. B., et al. (2012) · BMJ · doi:10.1136/bmj.e6698 · Cited by 379 · see citing works
Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota
Zhu, Y., Jameson, E., Crosatti, M., Schäfer, H., Rajakumar, K., Bugg, T. D. H., & Chen, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316569111 · Cited by 372 · see citing works
Fish Consumption and Incidence of Stroke: A Meta-Analysis of Cohort Studies
He, K., Song, Y., Daviglus, M. L., Liu, K., Van Horn, L., Dyer, A. R., Goldbourt, U., & Greenland, P. (2004) · Stroke · doi:10.1161/01.str.0000130856.31468.47 · Cited by 371 · see citing works
Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis
Miao, J., Ling, A. V., Manthena, P. V., Gearing, M. E., Graham, M. J., Crooke, R. M., Croce, K. J., Esquejo, R. M., Clish, C. B., Morbid Obesity Study Group, et al. (2015) · Nature Communications · doi:10.1038/ncomms7498 · Cited by 368 · see citing works
Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet
Gao, X., Liu, X., Xu, J., Xue, C., Xue, Y., & Wang, Y. (2014) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2014.03.001 · Cited by 360 · see citing works
Missailidis, C., Hällqvist, J., Qureshi, A. R., Barany, P., Heimbürger, O., Lindholm, B., Stenvinkel, P., & Bergman, P. (2016) · PLOS ONE · doi:10.1371/journal.pone.0141738 · Cited by 338 · see citing works
Shih, D. M., Wang, Z., Lee, R., Meng, Y., Che, N., Charugundla, S., Qi, H., Wu, J., Pan, C., Brown, J. M., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m051680 · Cited by 335 · see citing works
The gut microbiome, diet, and links to cardiometabolic and chronic disorders
Aron‐Wisnewsky, J., & Clément, K. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.191 · Cited by 327 · see citing works
Tang, W. H. W., Wang, Z., Shrestha, K., Borowski, A. G., Wu, Y., Troughton, R. W., Klein, A. L., & Hazen, S. L. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.11.006 · Cited by 325 · see citing works
Bennion, B. J., & Daggett, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308633101 · Cited by 310 · see citing works
A Combined Epidemiologic and Metabolomic Approach Improves CKD Prediction
Rhee, E. P., Clish, C. B., Ghorbani, A., Larson, M. G., Elmariah, S., McCabe, E., Yang, Q., Cheng, S., Pierce, K., Deik, A., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012101006 · Cited by 307 · see citing works
Mouse models of experimental atherosclerosis.
Jawień, J., Nastałek, P., & Korbut, R. (2004) · PubMed · Cited by 295 · see citing works
Bain, M. A., Faull, R., Fornasini, G., Milne, R. W., & Evans, A. M. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk056 · Cited by 282 · see citing works
Senthong, V., Wang, Z., Li, X. S., Fan, Y., Wu, Y., Wilson Tang, W. H., & Hazen, S. L. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002816 · Cited by 270 · see citing works
Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis
Nagatomo, Y., & Tang, W. H. W. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.09.017 · Cited by 259 · see citing works
Bae, S., Ulrich, C. M., Neuhouser, M. L., Malysheva, O., Bailey, L. B., Xiao, L., Brown, E. C., Cushing-Haugen, K. L., Zheng, Y., Cheng, T.-Y. D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1835 · Cited by 253 · see citing works
Formation of methylamines from ingested choline and lecithin.
Zeisel, S. H., Wishnok, J. S., & Blusztajn, J. K. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33590-1 · Cited by 253 · see citing works
Self-citationBrugère, J.-F., Borrel, G., Gaci, N., Tottey, W., O’Toole, P. W., & Malpuech-Brugère, C. (2014) · Gut Microbes · doi:10.4161/gmic.26749 · Cited by 249 · see citing works
Human Hepatic Flavin-Containing Monooxygenases 1 (FMO1) and 3 (FMO3) Developmental Expression
Koukouritaki, S. B., Simpson, P., Yeung, C. K., Rettie, A. E., & Hines, R. N. (2002) · Pediatric Research · doi:10.1203/00006450-200202000-00018 · Cited by 245 · see citing works
Senthong, V., Li, X. S., Hudec, T., Coughlin, J., Wu, Y., Levison, B., Wang, Z., Hazen, S. L., & Tang, W. H. W. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.546 · Cited by 242 · see citing works
Miller, C. A., Corbin, K. D., da Costa, K.-A., Zhang, S., Zhao, X., Galanko, J. A., Blevins, T., Bennett, B. J., O’Connor, A., & Zeisel, S. H. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.087692 · Cited by 240 · see citing works
Self-citationDNA damage and the DNA-activated protein kinase
Anderson, C. W. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90144-c · Cited by 235 · see citing works
Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels
Dambrova, M., Latkovskis, G., Kuka, J., Strele, I., Konrade, I., Grinberga, S., Hartmane, D., Pugovics, O., Erglis, A., & Liepinsh, E. (2016) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0035-1569330 · Cited by 229 · see citing works
Treacy, E. P. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.5.839 · Cited by 228 · see citing works
Lever, M., George, P. M., Slow, S., Bellamy, D., Young, J. M., Ho, M., McEntyre, C. J., Elmslie, J. L., Atkinson, W., Molyneux, S. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114969 · Cited by 223 · see citing works
Mueller, D. M., Allenspach, M., Othman, A., Saely, C. H., Muendlein, A., Vonbank, A., Drexel, H., & von Eckardstein, A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.10.091 · Cited by 217 · see citing works
DiNicolantonio, J. J., Lavie, C. J., Fares, H., Menezes, A. R., & O'Keefe, J. H. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.02.007 · Cited by 217 · cited 1× · see citing works
“A meta-analysis of 13 controlled trials (n = 3,629 people) reported that low oral dosage of L-carnitine resulted in 27% reduction in all-cause mortality, a 65% reduction in ventricular arrhythmias, and a 40% reduction in angina symptoms in patients who had an acute myocardial infarction (37).”
Trimethylaminuria: the fish malodor syndrome.
Mitchell, S. C., & Smith, R. L. (2001) · PubMed · Cited by 207 · see citing works
Uremia Accelerates both Atherosclerosis and Arterial Calcification in Apolipoprotein E Knockout Mice
Massy, Z. A., Ivanovski, O., Nguyen-Khoa, T., Angulo, J., Szumilak, D., Mothu, N., Phan, O., Daudon, M., Lacour, B., Dru[Combining Diaeresis]eke, T. B., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004060495 · Cited by 203 · see citing works
Trimethylamine oxide accumulation in marine animals: relationship to acylglycerol storagej
Seibel, B. A., & Walsh, P. J. (2002) · Journal of Experimental Biology · doi:10.1242/jeb.205.3.297 · Cited by 202 · see citing works
Entropic Stabilization of Proteins by TMAO
Cho, S. S., Reddy, G., Straub, J. E., & Thirumalai, D. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp207289b · Cited by 198 · see citing works
Rohrmann, S., Linseisen, J., Allenspach, M., von Eckardstein, A., & Müller, D. (2016) · The Journal of Nutrition · doi:10.3945/jn.115.220103 · Cited by 197 · cited 1× · see citing works
“In a small study in healthy Bavarian subjects, dietary intake of fish, meat, or eggs was not associated with plasma TMAO concentrations, but dairy intake was positively associated with plasma TMAO concentrations (94).”
BackgroundThe exogenous origin of trimethylamine in the mouse
Al-Waiz, M., Mikov, M., Mitchell, S. C., & Smith, R. L. (1992) · Metabolism · doi:10.1016/0026-0495(92)90140-6 · Cited by 196 · see citing works
Xu, R., Wang, Q., & Li, L. (2015) · BMC Genomics · doi:10.1186/1471-2164-16-s7-s4 · Cited by 193 · see citing works
Collins, H. L., Drazul-Schrader, D., Sulpizio, A. C., Koster, P. D., Williamson, Y., Adelman, S. J., Owen, K., Sanli, T., & Bellamine, A. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.10.108 · Cited by 189 · see citing works
Microbiology Meets Big Data: The Case of Gut Microbiota–Derived Trimethylamine
Falony, G., Vieira-Silva, S., & Raes, J. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104422 · Cited by 187 · see citing works
Mondul, A. M., Moore, S. C., Weinstein, S. J., Karoly, E. D., Sampson, J. N., & Albanes, D. (2015) · International Journal of Cancer · doi:10.1002/ijc.29576 · Cited by 179 · see citing works
Kim, R. B., Morse, B. L., Djurdjev, O., Tang, M., Muirhead, N., Barrett, B., Holmes, D. T., Madore, F., Clase, C. M., Rigatto, C., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.01.014 · Cited by 179 · see citing works
Posada-Ayala, M., Zubiri, I., Martin-Lorenzo, M., Sanz-Maroto, A., Molero, D., Gonzalez-Calero, L., Fernandez-Fernandez, B., de la Cuesta, F., Laborde, C. M., Barderas, M. G., et al. (2014) · Kidney International · doi:10.1038/ki.2013.328 · Cited by 167 · see citing works
The Apolipoprotein E Knockout Mouse: A Model Documenting Accelerated Atherogenesis In Uremia
Buzello, M., Törnig, J., Faulhaber, J., Ehmke, H., Ritz, E., & Amann, K. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000045048.71975.fc · Cited by 167 · see citing works
Meyer, K. A., Benton, T. Z., Bennett, B. J., Jacobs, D. R., Lloyd‐Jones, D. M., Gross, M. D., Carr, J. J., Gordon‐Larsen, P., & Zeisel, S. H. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003970 · Cited by 167 · see citing works
Self-citationBorrel, G., Harris, H. M. B., Tottey, W., Mihajlovski, A., Parisot, N., Peyretaillade, E., Peyret, P., Gribaldo, S., O'Toole, P. W., & Brugère, J.-F. (2012) · Journal of Bacteriology · doi:10.1128/jb.01867-12 · Cited by 166 · see citing works
Kaysen, G. A., Johansen, K. L., Chertow, G. M., Dalrymple, L. S., Kornak, J., Grimes, B., Dwyer, T., Chassy, A. W., & Fiehn, O. (2015) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2015.02.006 · Cited by 164 · see citing works
Structure and Interaction in Aqueous Urea−Trimethylamine-N-oxide Solutions
Paul, S., & Patey, G. N. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0685506 · Cited by 158 · see citing works
Egg Phospholipids and Cardiovascular Health
Blesso, C. N. (2015) · Nutrients · doi:10.3390/nu7042731 · Cited by 157 · see citing works
Bidulescu, A., Chambless, L. E., Siega-Riz, A. M., Zeisel, S. H., & Heiss, G. (2007) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-7-20 · Cited by 153 · see citing works
Self-citationAthawale, M. V., Dordick, J. S., & Garde, S. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.056671 · Cited by 153 · see citing works
Zeisel, S. H., daCosta, K. A., Youssef, M., & Hensey, S. (1989) · The Journal of Nutrition · doi:10.1093/jn/119.5.800 · Cited by 151 · see citing works
Self-citationBell, J. D., Lee, J. A., Lee, H. A., Sadler, P. J., Wilkie, D. R., & Woodham, R. H. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(91)90046-c · Cited by 147 · see citing works
QUANTITATIVE ANALYSIS OF FMO GENE mRNA LEVELS IN HUMAN TISSUES
Zhang, J., & Cashman, J. R. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006171 · Cited by 144 · see citing works
The metabolism of<sup>14</sup>C-labelled trimethylamine and its<i>N</i>-oxide in man
Al-waiz, M., Mitchell, S. C., Idle, J. R., & Smith, R. L. (1987) · Xenobiotica · doi:10.3109/00498258709043962 · Cited by 143 · see citing works
Hartiala, J., Bennett, B. J., Tang, W. H. W., Wang, Z., Stewart, A. F. R., Roberts, R., McPherson, R., Lusis, A. J., Hazen, S. L., & Allayee, H. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303252 · Cited by 133 · see citing works
Human Flavin-Containing Monooxygenase Substrate Specificity and Role in Drug Metabolism
Cashman, J. (2000) · Current Drug Metabolism · doi:10.2174/1389200003339135 · Cited by 132 · see citing works
Dalmeijer, G. W., Olthof, M. R., Verhoef, P., Bots, M. L., & van der Schouw, Y. T. (2008) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602725 · Cited by 131 · see citing works
Mente, A., Chalcraft, K., Ak, H., Davis, A. D., Lonn, E., Miller, R., Potter, M. A., Yusuf, S., Anand, S. S., & McQueen, M. J. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.06.016 · Cited by 128 · see citing works
Human Trace Amine-Associated Receptor TAAR5 Can Be Activated by Trimethylamine
Wallrabenstein, I., Kuklan, J., Weber, L., Zborala, S., Werner, M., Altmüller, J., Becker, C., Schmidt, A., Hatt, H., Hummel, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054950 · Cited by 122 · see citing works
Mechanism of Prominent Trimethylamine Oxide (TMAO) Accumulation in Hemodialysis Patients
Hai, X., Landeras, V., Dobre, M. A., DeOreo, P., Meyer, T. W., & Hostetter, T. H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143731 · Cited by 122 · see citing works
Obeid, R., Awwad, H. M., Rabagny, Y., Graeber, S., Herrmann, W., & Geisel, J. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.121269 · Cited by 117 · see citing works
Intra-individual variation of plasma trimethylamine-N-oxide (TMAO), betaine and choline over 1 year
Kühn, T., Rohrmann, S., Sookthai, D., Johnson, T., Katzke, V., Kaaks, R., von Eckardstein, A., & Müller, D. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0374 · Cited by 110 · see citing works
Hand, S. C., & Somero, G. N. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68257-8 · Cited by 106 · see citing works
Huo, T., Cai, S., Lu, X., Sha, Y., Yu, M., & Li, F. (2009) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2009.01.008 · Cited by 104 · see citing works
Mafune, A., Iwamoto, T., Tsutsumi, Y., Nakashima, A., Yamamoto, I., Yokoyama, K., Yokoo, T., & Urashima, M. (2016) · Clinical and Experimental Nephrology · doi:10.1007/s10157-015-1207-y · Cited by 103 · see citing works
Millard, H. R., Musani, S. K., Dibaba, D. T., Talegawkar, S. A., Taylor, H. A., Tucker, K. L., & Bidulescu, A. (2018) · European Journal of Nutrition · doi:10.1007/s00394-016-1296-8 · Cited by 101 · see citing works
Zheng, Y., Li, Y., Rimm, E. B., Hu, F. B., Albert, C. M., Rexrode, K. M., Manson, J. E., & Qi, L. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.131771 · Cited by 100 · see citing works
Trimethylamine: Metabolic, Pharmacokinetic and Safety Aspects
Bain, M., Fornasini, G., & Evans, A. (2005) · Current Drug Metabolism · doi:10.2174/1389200054021807 · Cited by 98 · see citing works
Kuka, J., Liepinsh, E., Makrecka-Kuka, M., Liepins, J., Cirule, H., Gustina, D., Loza, E., Zharkova-Malkova, O., Grinberga, S., Pugovics, O., et al. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.09.028 · Cited by 97 · see citing works
Cashman, J. R., Xiong, Y., Lin, J., Verhagen, H., van Poppel, G., van Bladeren, P. J., Larsen-Su, S., & Williams, D. E. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00166-5 · Cited by 93 · see citing works
Mills, G. A., Walker, V., & Mughal, H. (1999) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(98)00542-8 · Cited by 90 · see citing works
Trøseid, M., Hov, J. R., Nestvold, T. K., Thoresen, H., Berge, R. K., Svardal, A., & Lappegård, K. T. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0120 · Cited by 84 · see citing works
Fukami, K., Yamagishi, S.-I., Sakai, K., Kaida, Y., Yokoro, M., Ueda, S., Wada, Y., Takeuchi, M., Shimizu, M., Yamazaki, H., et al. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000197 · Cited by 84 · see citing works
Metaorganismal nutrient metabolism as a basis of cardiovascular disease
Brown, J. M., & Hazen, S. L. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000036 · Cited by 80 · see citing works
Transient trimethylaminuria related to menstruation
Shimizu, M., Cashman, J. R., & Yamazaki, H. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-2 · Cited by 72 · see citing works
Increase in human exposure to methylamine precursors of N-nitrosamines after eating fish.
Zeisel, S. H., & daCosta, K. A. (1986) · PubMed · Cited by 70 · see citing works
Self-citationUrinary excretion of methylamines in men with varying intake of fish from the baltic sea
Svensson, B. ‐., Åkesson, B., Nilsson, A., & Paulsson, K. (1994) · Journal of Toxicology and Environmental Health · doi:10.1080/15287399409531853 · Cited by 66 · see citing works
Emerging roles of flavin monooxygenase 3 in cholesterol metabolism and atherosclerosis
Schugar, R. C., & Brown, J. M. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000215 · Cited by 65 · see citing works
Zhao, X., Zeisel, S. H., & Zhang, S. (2015) · Electrophoresis · doi:10.1002/elps.201500055 · Cited by 63 · see citing works
Self-citationDambrova, M., Skapare‐Makarova, E., Konrade, I., Pugovics, O., Grinberga, S., Tirzite, D., Petrovska, R., Kalvins, I., & Liepins, E. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.135 · Cited by 63 · see citing works
Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine
Spence, J. D., Urquhart, B. L., & Bang, H. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv380 · Cited by 58 · see citing works
Barton, S., Navarro, S. L., Buas, M. F., Schwarz, Y., Gu, H., Djukovic, D., Raftery, D., Kratz, M., Neuhouser, M. L., & Lampe, J. W. (2015) · Food & Function · doi:10.1039/c5fo00287g · Cited by 55 · see citing works
Johnson, D. W. (2007) · Journal of Mass Spectrometry · doi:10.1002/jms.1339 · Cited by 55 · see citing works
Toxicometabolomics of Urinary Biomarkers for Human Gastric Cancer in a Mouse Model
Kim, K.-B., Yang, J.-Y., Kwack, S. J., Park, K. L., Kim, H. S., Ryu, D. H., Kim, Y.-J., Hwang, G.-S., & Lee, B. M. (2010) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/15287394.2010.511545 · Cited by 55 · see citing works
Validation of 1H NMR spectroscopy as an analytical tool for methylamine metabolites in urine
Lee, M. B. H., Storer, M., Blunt, J. W., et al. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.09.004 · Cited by 49 · see citing works
Fish odour syndrome: Verification of carrier detection test
Zhang, A. Q., Mitchell, S., & Smith, R. (1995) · Journal of Inherited Metabolic Disease · doi:10.1007/bf02436755 · Cited by 44 · see citing works
Xu, J., Zhang, J., Cai, S., Dong, J., Yang, J. Y., & Chen, Z. (2009) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-009-2623-1 · Cited by 43 · see citing works
Haissman, J. M., Knudsen, A., Hoel, H., Kjær, A., Kristoffersen, U. S., Berge, R. K., Katzenstein, T. L., Svardal, A. M., Ueland, T., Aukrust, P., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000843 · Cited by 43 · see citing works
Zeisel, S. H., daCosta, K. A., & LaMont, J. T. (1988) · Carcinogenesis · doi:10.1093/carcin/9.1.179 · Cited by 41 · see citing works
Self-citationEffect of molecular crowding on the enzymes of glycogenolysis
Chebotareva, N. A. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907130056 · Cited by 38 · see citing works
Li, X., Chen, Y., Liu, J., Yang, G., Zhao, J., Liao, G., Shi, M., Yuan, Y., He, S., Lu, Y., et al. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.012157 · Cited by 33 · see citing works
Converging on a mechanism for choline degradation
Thibodeaux, C. J., & van der Donk, W. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219534110 · Cited by 28 · see citing works
Risk Prediction in CKD: The Rational Alignment of Health Care Resources in CKD 4/5 Care
Wojciechowski, P. W., Tangri, N., Rigatto, C., et al. (2016) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2016.04.002 · Cited by 28 · see citing works
Chao, C.-K., & Zeisel, S. H. (1990) · The Journal of Nutritional Biochemistry · doi:10.1016/0955-2863(90)90055-p · Cited by 23 · see citing works
Self-citationHsu, W.-Y., Lo, W., Lai, C., Tsai, F., Tsai, C., Tsai, Y., Lin, W., & Chao, M. (2007) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3043 · Cited by 22 · see citing works
Pharmacokinetics of trimethylamine in rats, including the effects of a synthetic diet
Nnane, I. P., & Damani, L. A. (2001) · Xenobiotica · doi:10.1080/00498250110065586 · Cited by 21 · see citing works
Trimethylamine N-Oxide as a Novel Therapeutic Target in CKD
Tang, W. H. W. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050576 · Cited by 14 · see citing works
Flagged first, then by citations
Research works printed but not linked: 9
- Chebotareva NA, 2007, Biochemistry, 72, 1478
- Hand SC, 1986, Am. J. Physiol., 250, R505
- Herlaar E, 1999, Trends Mol. Med., 5, 439
- Jawien J, 2004, J. Physiol. Pharmacol., 55, 503
- Mackay RJ, 2011, Clin. Biochem. Rev., 32, 33
- Mitchell SC, 2001, Drug Metab. Dispos., 29, 517
- US Dep. Aric., 2008, USDA Database for the Choline Content of Common Foods, Release 2
- Zeisel SH, 1986, Cancer Res, 46, 6136
- 10.1093/jn/133.5.1302 · DOI · Paper page
Cited by
Sorted by citations
Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171 · see citing works
“Mechanistically, TMAO can activate the mitogenactivated protein kinase (MAPK) and NF-κB signaling pathways in endothelial cells and smooth muscle cells.(132) The MAPK signaling pathway can be stimulated by growth factors, pathogen-associated molecules, and inflammatory cytokines, which follows by a MAPKKK-MAPKK-MAPK-T…”
BackgroundYang, W., & Cong, Y. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00661-4 · Cited by 701 · see citing works
Janeiro, M., Ramírez, M., Milagro, F., Martínez, J., & Solas, M. (2018) · Nutrients · doi:10.3390/nu10101398 · Cited by 631 · see citing works
“Some studies revealed that the genes CutC and CutD, which are present in the cluster Cut, are indispensable for Desulfovibrio alaskensis and Desulfovibrio desulfuricans to transform choline into TMA [18].”
BackgroundInfluentialHow the immune system shapes atherosclerosis: roles of innate and adaptive immunity
Roy, P., Orecchioni, M., & Ley, K. F. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00584-1 · Cited by 584 · see citing works
Microbiome–metabolome reveals the contribution of gut–kidney axis on kidney disease
Chen, Y., Chen, D., Chen, L., Liu, J., Vaziri, N. D., Guo, Y. P., & Zhao, Y. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-018-1756-4 · Cited by 430 · see citing works
Gut microbiota and cardiovascular disease: opportunities and challenges
Kazemian, N., Mahmoudi, M., Halperin, F. A., Wu, J. C., & Pakpour, S. (2020) · Microbiome · doi:10.1186/s40168-020-00821-0 · Cited by 392 · see citing works
Yang, S., Li, X., Yang, F., Zhao, R., Pan, X., Liang, J., Tian, L., Li, X., Liu, L., Xing, Y., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01360 · Cited by 347 · see citing works
“, 2013; Ma and Li, 2018), as it has been shown to be essential for converting dietary compounds into TMA in gnotobiotic mice and human studies (Wang et al., 2011; Tang and Hazen, 2014; Zeisel and Warrier, 2017), and changes in the gut microbiota have marked effects on TMAO levels.”
BackgroundThe Impact of CKD on Uremic Toxins and Gut Microbiota
Rysz, J., Franczyk, B., Ławiński, J., Olszewski, R., Ciałkowska-Rysz, A. D., & Gluba-Brzózka, A. (2021) · Toxins · doi:10.3390/toxins13040252 · Cited by 314 · see citing works
“Trimethylamine formed in the first step is later absorbed and converted to TMAO by flavin monooxygenase enzymes in the liver [134].”
BackgroundGut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Shen, Y., Fan, N., Ma, S., Cheng, X., Yang, X., & Wang, G. (2025) · MedComm · doi:10.1002/mco2.70168 · Cited by 364 · see citing works
Handelsman, Y., Jellinger, P. S., Guerin, C. K., Bloomgarden, Z. T., Brinton, E. A., Budoff, M. J., Davidson, M. H., Einhorn, D., Fazio, S., Fonseca, V. A., et al. (2020) · Endocrine Practice · doi:10.4158/cs-2020-0490 · Cited by 248 · see citing works
“One mechanism might be that meat and dairy cause higher levels of trimethylamine N-oxide, which has been associated with development and progression of atherosclerosis, primarily by altering the gut microbiome (47).”
Rethinking healthy eating in light of the gut microbiome
Armet, A. M., Deehan, E. C., O’Sullivan, A. F., Mota, J. F., Field, C. J., Prado, C. M., Lucey, A. J., & Walter, J. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.04.016 · Cited by 252 · see citing works
Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II–induced hypertension
Jiang, S., Shui, Y., Cui, Y., Tang, C., Wang, X., Qiu, X., Hu, W., Fei, L., Li, Y., Zhang, S., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102115 · Cited by 237 · see citing works
Liu, Y., & Dai, M. (2020) · Mediators of Inflammation · doi:10.1155/2020/4634172 · Cited by 232 · see citing works
“For humans, most of the plasma cholesterol is contained in low-density lipoprotein (LDL) particles, whereas most of their cholesterol is in high-density lipoprotein (HDL) particles for mice.”
BackgroundInfluentialThe gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases
Zhen, J., Zhou, Z., He, M., Han, H.-X., Lv, E., Wen, P., Liu, X., Wang, Y., Cai, X., Tian, J., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1085041 · Cited by 241 · see citing works
“L-carnitine is predominantly contained in red meat (35), while most betaine is found in fish, beetroot, and grains grown in high osmotic environments, such as beans (36).”
BackgroundTrimethylamine N-oxide (TMAO) in human health
Gątarek, P., & Kałużna-Czaplińska, J. (2020) · EXCLI journal · doi:10.17179/excli2020-3239 · Cited by 233 · see citing works
“TMA is formed from the dietary compounds present in the diet, which is then immediately absorbed and converted into TMA by various enzymes (Wang et al., 2019; Zeisel and Warrier, 2017).”
BackgroundKonopelski, P., & Mogilnicka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031222 · Cited by 218 · see citing works
“TMAO synthesis increases after phosphatidylcholine- and L-carnitine-rich meals [53], and depends on the metabolism by gut microbiota, which was demonstrated in humans [54].”
BackgroundInfluentialFeng, Y., Cao, G., Chen, D., Vaziri, N. D., Chen, L., Zhang, J., Wang, M., Guo, Y. P., & Zhao, Y. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03155-9 · Cited by 201 · see citing works
Wu, M., Yang, S., Wang, S., Cao, Y., Zhao, R., Li, X., Xing, Y., & Liu, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00223 · Cited by 201 · see citing works
Gut microbiota in atherosclerosis: focus on trimethylamine N‐oxide
Zhu, Y., Li, Q., & Jiang, H. (2020) · Apmis · doi:10.1111/apm.13038 · Cited by 204 · see citing works
Arias, N., Arboleya, S., Allison, J., Kaliszewska, A., Higarza, S. G., Gueimonde, M., & Arias, J. L. (2020) · Nutrients · doi:10.3390/nu12082340 · Cited by 200 · see citing works
Ge, X., Zheng, L., Zhuang, R., Yu, P., Xu, Z., Liu, G., Xi, X., Zhou, X., & Fan, H. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz064 · Cited by 195 · see citing works
“trimethylamine (TMA) by hepatic flavin-dependent monooxygenases (14, 15).”
BackgroundCanyelles, M., Tondo, M., Cedó, L., Farràs, M., Escolá‐Gil, J. C., & Blanco‐Vaca, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103228 · Cited by 194 · see citing works
Microbial Contribution to the Human Metabolome: Implications for Health and Disease
Treuren, W. V., & Dodd, D. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043559 · Cited by 176 · see citing works
“Given how the story of TMAO and CVD has captivated physicians, nutritionists, and microbiologists alike, there is no doubt that future studies will seek to address these questions.”
BackgroundInfluentialThe Gut Microbial Bile Acid Modulation and Its Relevance to Digestive Health and Diseases
Fogelson, K. A., Dorrestein, P. C., Zarrinpar, A., & Knight, R. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.02.022 · Cited by 177 · see citing works
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment
Targher, G., Corey, K. E., & Byrne, C. D. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.101215 · Cited by 170 · see citing works
Wallace, T. C., Blusztajn, J. K., Caudill, M. A., Klatt, K. C., Natker, E., Zeisel, S. H., & Zelman, K. M. (2018) · Nutrition Today · doi:10.1097/nt.0000000000000302 · Cited by 169 · see citing works
Self-citationNie, J., Xie, L., Zhao, B.-X., Li, Y., Qiu, B., Zhu, F., Li, G.-F., He, M., Wang, Y., Wang, B., et al. (2018) · Stroke · doi:10.1161/strokeaha.118.021997 · Cited by 163 · see citing works
Wu, W., Chen, C., Liu, P., Panyod, S., Liao, B., Chen, P.-C., Kao, H., Kuo, H., Kuo, C., Chiu, T. H. T., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-317155 · Cited by 156 · see citing works
Clinical epidemiology of infectious disease among patients with chronic kidney disease
Ishigami, J., & Matsushita, K. (2018) · Clinical and Experimental Nephrology · doi:10.1007/s10157-018-1641-8 · Cited by 166 · see citing works
Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease
Roncal, C., Martínez-Aguilar, E., Orbe, J., Ravassa, S., Fernández‐Montero, A., Saenz‐Pipaon, G., Ugarte, A., de Mendoza, A. E., Rodríguez, J. A., Fernandez-Alonso, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52082-z · Cited by 160 · see citing works
Bioactivity and health effects of ruminant meat lipids. Invited Review
Vahmani, P., Ponnampalam, E. N., Kraft, J., Mapiye, C., Bermingham, E. N., Watkins, P. J., Proctor, S. D., & Dugan, M. E. R. (2020) · Meat Science · doi:10.1016/j.meatsci.2020.108114 · Cited by 168 · see citing works
McClements, D. J. (2020) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2020.106404 · Cited by 162 · see citing works
The gut microbiome and cardiovascular disease: current knowledge and clinical potential
Ahmad, A. F., Dwivedi, G., O’Gara, F., Caparros-Martin, J. A., & Ward, N. C. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00376.2019 · Cited by 153 · see citing works
Trimethylamine N-Oxide in Relation to Cardiometabolic Health—Cause or Effect?
Papandreou, C., Moré, M. I., & Bellamine, A. (2020) · Nutrients · doi:10.3390/nu12051330 · Cited by 150 · see citing works
“However, current reviews critically evaluating the cause to effect relationship and the nature of TMAO’s association to cardiometabolic diseases are missing [8].”
BackgroundInfluentialBenítez‐Páez, A., Kjølbæk, L., del Pulgar, E. M. G., Brahe, L. K., Astrup, A. V., Matysik, S., Schött, H.-F., Krautbauer, S., Liebisch, G., Boberska, J., et al. (2019) · mSystems · doi:10.1128/msystems.00209-19 · Cited by 136 · see citing works
Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder
Luqman, A., Hassan, A., Ullah, M., Naseem, S., Ullah, M., Zhang, L., Din, A. U., Ullah, K., Ahmad, W., & Wang, G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1321395 · Cited by 138 · see citing works
Yang, W., Zhang, S., Zhu, J., Jiang, H., Jia, D., Ou, T., Qi, Z., Zou, Y., Qian, J., Sun, A., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.07.004 · Cited by 115 · see citing works
Precision (Personalized) Nutrition: Understanding Metabolic Heterogeneity
Zeisel, S. H. (2020) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-032519-051736 · Cited by 130 · see citing works
Self-citationRisk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease
Mantovani, A., Byrne, C. D., Benfari, G., Bonapace, S., Simon, T. G., & Targher, G. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.11.007 · Cited by 114 · see citing works
Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far?
Coutinho‐Wolino, K. S., Cardozo, L., Leal, V. D. O., Mafra, D., & Stockler‐Pinto, M. B. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02491-6 · Cited by 112 · see citing works
“Nowadays, it is common knowledge that TMAO can act as an active chemical molecule, which is capable of interfering in the homeostasis of several metabolic pathways in humans, thereby contributing to the development of chronic diseases such as atherosclerosis, diabetes, and kidney diseases [32] (Fig.”
BackgroundWinther, S. A., Oellgaard, J., Tofte, N., Tarnow, L., Wang, Z., Ahluwalia, T. S., Jorsal, A., Theilade, S., Parving, H., Hansen, T. W., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0048 · Cited by 111 · see citing works
“Thus, it has been speculated that TMAO is a biomarker associated with CVD but not the cause of CVD (35), even though it has been the”
BackgroundDiet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis
Quesada‐Vázquez, S., Aragonès, G., Bas-Prior, J. M. D., & Escoté, X. (2020) · Cells · doi:10.3390/cells9010176 · Cited by 106 · see citing works
“VLDL production and the hepatic lipid transfer are modulated by dietary choline, and the choline metabolism is affected by the gut microbiota dysbiosis [33].”
BackgroundDietary Strategies for Management of Metabolic Syndrome: Role of Gut Microbiota Metabolites
Croci, S., D'Apolito, L. I., Gasperi, V., Catani, M. V., & Savini, I. (2021) · Nutrients · doi:10.3390/nu13051389 · Cited by 108 · see citing works
“activity; it is noteworthy that TMA-producing bacterial strains (such as Escherichia fergusonii, Clostridium sporogenes, and Proteus penneri) have been detected in the human gut [31,85].”
BackgroundPraveenraj, S. S., Sonali, S., Anand, N., Hediyal, T. A., Vichitra, C., Kalyan, M., Kanna, P. V., Chandana, K. A., Paneyala, S., Mahalakshmi, A. M., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02990-5 · Cited by 112 · see citing works
“These two steps are called microbiotadependent pathways and human endogenous pathways, respectively [6, 40, 41].”
BackgroundNutritional Influences on One-Carbon Metabolism: Effects on Arsenic Methylation and Toxicity
Bozack, A. K., Saxena, R., & Gamble, M. V. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082117-051757 · Cited by 104 · see citing works
“While TMAO has been linked to risk for cardiovascular disease (150), it is unclear whether or not this relationship is causal (174).”
The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
Huang, Y., Xin, W., Xiong, J., Yao, M., Zhang, B., & Zhao, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.837500 · Cited by 92 · see citing works
“, 2017), and studies have demonstrated a positive correlation between the level of Enterococcus and the concentration of Trimethylamine N-Oxide (TMAO), which can serve as a potential biomarker of renal or cardiac dysfunction (Tang et al., 2015; Xu et al., 2017; Zeisel and Warrier, 2017; Liu et al., 2019).”
BackgroundInfluentialZeisel, S. H., Klatt, K. C., & Caudill, M. A. (2018) · Advances in Nutrition · doi:10.1093/advances/nmx004 · Cited by 98 · see citing works
Self-citationPharmacological Activities, Therapeutic Effects, and Mechanistic Actions of Trigonelline
Nguyen, V., Taine, E. G., Meng, D., Cui, T., & Tan, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063385 · Cited by 105 · see citing works
“In adult rats with isoproterenol (ISO)-induced myocardial dysfunctions, TRG prevented ISO-induced myocardial injury by downregulating the expression of the proteins Hsp27 and α B-crystallin [34].”
BackgroundGut Microbial Metabolite Trimethylamine N -Oxide Aggravates Pulmonary Hypertension
Huang, Y., Lin, F., Tang, R., Bao, C., Zhou, Q., Ye, K., Shen, Y., Liu, C., Hong, C., Yang, K., et al. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0414oc · Cited by 82 · see citing works
Gut bacterial phospholipase Ds support disease-associated metabolism by generating choline
Chittim, C. L., Campo, A. M.-D., & Balskus, E. P. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0294-4 · Cited by 92 · see citing works
Contribution of Trimethylamine N-Oxide (TMAO) to Chronic Inflammatory and Degenerative Diseases
Constantino-Jonapa, L. A., Espinoza-Palacios, Y., Escalona‐Montaño, A. R., Hernández-Ruiz, P., Amezcua-Guerra, L. M., Amedei, A., & Aguirre‐García, M. M. (2023) · Biomedicines · doi:10.3390/biomedicines11020431 · Cited by 97 · see citing works
“For example, it acts as a protein stabilizer, preserving its structure and enzymatic activity as well as counteracting the effects of pH, urea, and increased pressure [6].”
Shanmugham, M., Bellanger, S., & Leo, C. H. (2023) · Pharmaceuticals · doi:10.3390/ph16040504 · Cited by 96 · see citing works
“In most individuals, about half of the TMAO generated is excreted without any modifications within 24 h, through urine (95%), feces (4%), as well as by sweat and breath (less than 1%) [23].”
BackgroundMetabolic functions of the human gut microbiota: the role of metalloenzymes
Rajakovich, L. J., & Balskus, E. P. (2018) · Natural Product Reports · doi:10.1039/c8np00074c · Cited by 89 · see citing works
A Clinician’s Guide for Trending Cardiovascular Nutrition Controversies
Freeman, A. M., Morris, P. B., Aspry, K. E., Gordon, N. F., Barnard, N. D., Esselstyn, C. B., Ros, E., Devries, S. R., O’Keefe, J. H., Miller, M. J., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.030 · Cited by 93 · see citing works
“Another concern has been the relatively high content of trimethylamine N-oxide in fish (129), a molecule that may be detrimental for CV and general health (130).”
BackgroundYang, P., Li, X., Song, B., He, M. R., Wu, C., & Leng, X. (2021) · Aquaculture and Fisheries · doi:10.1016/j.aaf.2021.03.003 · Cited by 83 · see citing works
Li, T., Gua, C., Wu, B., & Chen, Y. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.069 · Cited by 86 · see citing works
Álvarez‐Mercado, A. I., & Plaza‐Díaz, J. (2022) · Nutrients · doi:10.3390/nu14194116 · Cited by 91 · see citing works
“Smooth muscle cells and endothelial cells can respond to TMAO by triggering the nuclear factor kappa-B (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways [48].”
BackgroundServillo, L., D’Onofrio, N., Giovane, A., Casale, R., Cautela, D., Castaldo, D., Iannaccone, F., Neglia, G., Campanile, G., & Balestrieri, M. L. (2018) · Food Chemistry · doi:10.1016/j.foodchem.2018.03.114 · Cited by 76 · see citing works
Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases
Stec, A., Sikora, M., Maciejewska, M., Paralusz-Stec, K., Michalska, M. N., Sikorska, E., & Rudnicka, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043494 · Cited by 85 · see citing works
Holmes, A., Finger, C. E., Morales‐Scheihing, D., Lee, J., & McCullough, L. D. (2020) · Translational research · doi:10.1016/j.trsl.2020.07.012 · Cited by 87 · see citing works
“Elevated TMAO levels are associated with an increased risk of atherosclerosis and other chronic vascular diseases (93, 94).”
BackgroundNguyen, T. T., Kościółek, T., Daly, R. E., Vázquez‐Baeza, Y., Swafford, A. D.-E., Knight, R. D., & Jeste, D. V. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.10.003 · Cited by 87 · see citing works
Yu, D., Shu, X., Rivera, E. S., Zhang, X., Cai, Q., Calcutt, M. W., Xiang, Y., Li, H., Gao, Y., Wang, T. J., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010606 · Cited by 79 · see citing works
“T rimethylamine-N-oxide (TMAO) has gained much attention recently because of its potential adverse effects on atherosclerosis and cardiovascular disease (CVD).(1,2) TMAO is a gut microbial–host cometabolite of dietary trimethylamines (mainly choline and carnitine).”
BackgroundGood or bad: gut bacteria in human health and diseases
Wang, H., Wei, C.-X., Lu, M., & Zhu, L. (2018) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2018.1481350 · Cited by 84 · see citing works
Liang, Y., Dai, X., Cao, Y. L., Wang, X., Lu, J., Xie, L., Liu, K., & Li, X. (2022) · Biochimie · doi:10.1016/j.biochi.2022.10.009 · Cited by 79 · see citing works
Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease
Samarraie, A. A., Pichette, M., & Rousseau, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065420 · Cited by 76 · see citing works
Rajakovich, L. J., Fu, B., Bollenbach, M., & Balskus, E. P. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2101498118 · Cited by 74 · see citing works
Cardiorenal syndrome: clinical diagnosis, molecular mechanisms and therapeutic strategies
Zhao, B., Hu, X., Wang, W., & Zhou, Y. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01476-z · Cited by 80 · see citing works
“In addition, elevated serum TMAO levels are an independent risk factor for hospitalisation events in patients on haemodialysis [25, 26].”
Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes
Croyal, M., Saulnier, P., Aguesse, A., Gand, E., Ragot, S., Roussel, R., Halimi, J., Ducrocq, G., Cariou, B., Montaigne, D., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa188 · Cited by 70 · see citing works
Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?
Jiang, L., & Schnabl, B. (2020) · Physiology · doi:10.1152/physiol.00005.2020 · Cited by 64 · see citing works
Breast Cancer: Lifestyle, the Human Gut Microbiota/Microbiome, and Survivorship
Bodai, B. I., & Nakata, T. E. (2020) · The Permanente Journal · doi:10.7812/tpp/19.129 · Cited by 72 · see citing works
Roles of Gut Microbial Metabolites in Diabetic Kidney Disease
Fang, Q., Liu, N., Zheng, B., Guo, F., Zeng, X., Huang, X., & Ouyang, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.636175 · Cited by 69 · see citing works
“Moreover, in some bacteria of the gender Acinetobacter and Serratia, CntA and CntB gens encode the two subunits of the oxidoreductase enzyme necessary to convert L-carnitine into TMA (35).”
BackgroundSchneider, C., Okun, J. G., Schwarz, K. V., Hauke, J., Zorn, M., Nürnberg, C., Ungerer, M. N., Ringleb, P. A., & Mundiyanapurath, S. (2020) · European Journal of Neurology · doi:10.1111/ene.14253 · Cited by 64 · see citing works
“TMA is rapidly absorbed in the bloodstream and oxidized to TMAO by flavin-containing monooxygenase-3 and is subsequently secreted in urine [4].”
BackgroundYu, H., Geng, W., Zheng, Z., Gao, J., Guo, D., & Wang, Y. (2019) · Theranostics · doi:10.7150/thno.33459 · Cited by 68 · see citing works
“In people, TMAO is mostly eliminated from body though urine, and is also excreted though breathe and sweat [8].”
BackgroundMethodHuo, X., Li, J., Cao, Y., Li, S., Shao, P., Leng, J., Li, W., Liu, J., Yang, K., Ronald, C. W., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00710 · Cited by 65 · see citing works
TMAO, a seafood-derived molecule, produces diuresis and reduces mortality in heart failure rats
Gawryś-Kopczyńska, M., Konop, M., Maksymiuk, K. M., Kraszewska, K., Derzsi, L., Sozański, K., Hołyst, R., Pilz, M., Samborowska, E., Dobrowolski, L., et al. (2020) · eLife · doi:10.7554/elife.57028 · Cited by 67 · see citing works
Meng, F., Li, N., Li, D., Song, B., & Li, L. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.111902 · Cited by 67 · see citing works
Orman, M., Bodea, S., Funk, M. A., Campo, A. M.-D., Bollenbach, M., Drennan, C. L., & Balskus, E. P. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b04883 · Cited by 63 · see citing works
Costabile, G., Vetrani, C., Bozzetto, L., Giacco, R., Bresciani, L., Rio, D. D., Vitale, M., Pepa, G. D., Brighenti, F., Riccardi, G., et al. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab188 · Cited by 67 · see citing works
Myocardial infarction and gut microbiota: An incidental connection
Vahed, S. Z., Barzegari, A., Tamayo, M. Z., Letourneur, D., & Pavon‐Djavid, G. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.008 · Cited by 63 · see citing works
Targeting Trimethylamine N-Oxide: A New Therapeutic Strategy for Alleviating Atherosclerosis
Jing, L., Zhang, H., Xiang, Q., Shen, L., Guo, X., Zhai, C., & Hu, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.864600 · Cited by 66 · see citing works
“In addition to being excreted in the urine, TMAO can be eliminated through sweat, feces, and the respiratory tract (33).”
BackgroundBalancing the Equation: A Natural History of Trimethylamine and Trimethylamine-N-oxide
Loo, R. L., Chan, Q. M., Nicholson, J. K., & Holmes, E. C. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00851 · Cited by 60 · see citing works
Yang, J. J., Lipworth, L. P., Shu, X., Blot, W. J., Xiang, Y., Steinwandel, M. D., Li, H., Gao, Y., Zheng, W., & Yu, D. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz318 · Cited by 53 · see citing works
“Despite its vital role in the human body, choline can also serve as a dietary precursor of TMAO via the gut microbial metabolism (2), a potential risk factor for CVD and related deaths.”
BackgroundYuan, J., Liu, X., Liu, C., Ang, A. F., Massaro, J., Devine, S. A., Auerbach, S. H., Blusztajn, J. K., Au, R., & Jacques, P. F. (2022) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac193 · Cited by 61 · see citing works
“However, the role of choline-derived TMAO remains uncertain given that TMAO production could also be affected by the gut microbe and liver function.”
BackgroundInfluentialThe Liver as a Hub in Thermogenesis
Abumrad, N. A. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.018 · Cited by 63 · see citing works
“…L-carnitine is converted by gut microbiota to trimethylamine N-oxide (TMAO), which is associated with adverse cardiovascular outcomes, but a mechanistic understanding of this association and its relevance at L-carnitine levels used in health supplements is lacking (Zeisel and Warrier, 2017).”
BackgroundCholine Pathway Nutrients and Metabolites and Cognitive Impairment After Acute Ischemic Stroke
Zhong, C., Lu, Z., Che, B., Qian, S., Zheng, X., Wang, A., Bu, X., Zhang, J., Ju, Z., Xu, T., et al. (2021) · Stroke · doi:10.1161/strokeaha.120.031903 · Cited by 58 · see citing works
Heumel, S., Rodovalho, V. D. R., Urien, C., Specque, F., Rodrigues, P. B., Robil, C., Delval, L., Sencio, V., Descat, A., Deruyter, L., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2325067 · Cited by 63 · see citing works
“28 Relative to D0, the concentration of TMAO decreased significantly on D7 but recovered on D14 (Figure 4(b)).”
BackgroundVia, A. D., Gargari, G., Taverniti, V., Rondini, G., Velardi, I., Gambaro, V., Visconti, G. L., Vitis, V. D., Gardana, C., Ragg, E. M., et al. (2019) · Nutrients · doi:10.3390/nu12010062 · Cited by 62 · see citing works
“Then, approximately 95% of the absorbed TMA is oxidized in the liver by flavin monooxygenases and excreted in the urine within 24 h [31,39].”
BackgroundLiang, X., Zhang, Z., Lv, Y., Tong, L., Liu, T., Yi, H., Zhou, X., Yu, Z., Tian, X., Cui, Q., et al. (2020) · Nutrition · doi:10.1016/j.nut.2020.110941 · Cited by 62 · see citing works
Tacconi, E., Palma, G., Biase, D. D., Luciano, A., Barbieri, M., de Nigris, F., & Bruzzese, F. (2023) · Nutrients · doi:10.3390/nu15030563 · Cited by 62 · see citing works
“These bacteria produce toxic metabolites, such as secondary bile salt from primary bile salt, hydrogen sulfide, trimethylamine-Noxide (TMAO) from choline, indoxyl sulfate from amino acid tryptophan, and many more which are likely to promote inflammation, and prolonged inflammation can develop into cancer [5,7,31,32].”
BackgroundInfluentialTMA/TMAO in Hypertension: Novel Horizons and Potential Therapies
Zhang, W., Wang, Y., Zhang, A., Ding, Y., Zhang, X., Jia, Q.-J., Zhu, Y., Li, Y., Lv, S., & Zhang, J. (2021) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-021-10115-x · Cited by 59 · see citing works
Trimethylamine-N-Oxide Pathway: A Potential Target for the Treatment of MAFLD
Li, X., Hong, J. W., Wang, Y., Pei, M., Wang, L., & Gong, Z. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.733507 · Cited by 58 · see citing works
Luo, T., Guo, Z., Liu, D., Guo, Z., Wu, Q., Li, Q., Lin, R., Chen, P., Ou, C., & Chen, M. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2077602 · Cited by 56 · see citing works
“We observed that three kinds of TMA-producing strains, Clostridium-asparagiforme, Desulfovibriodesulfuricans and Desulfovibrio-alaskensi, were enriched in DKO mice, and these species have been reported to be classical bacteria governing choline-to-TMA transformation.(27,28) To achieve detailed mechanistic insight into…”
BackgroundNutrition, one-carbon metabolism and arsenic methylation
Abuawad, A. K., Bozack, A. K., Saxena, R., & Gamble, M. V. (2021) · Toxicology · doi:10.1016/j.tox.2021.152803 · Cited by 55 · see citing works
Gut Microbial-Derived Metabolites as Immune Modulators of T Helper 17 and Regulatory T Cells
Calvo‐Barreiro, L., Zhang, L., Abdel‐Rahman, S. A., Naik, S. P., & Gabr, M. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021806 · Cited by 61 · see citing works
Gut Microbiotic Features Aiding the Diagnosis of Acute Ischemic Stroke
Xiang, L., Lou, Y., Liu, L., Liu, Y., Zhang, W., Deng, J., Guan, Y., She, M., You, X., Liu, M., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.587284 · Cited by 55 · see citing works
“TMAO is produced when hepatic flavin mono-oxygenases act on trimethylamine, a waste product of gut microbes (Zeisel and Warrier, 2017).”
BackgroundAlzheimer’s disease and gut microbiota: does trimethylamine N-oxide (TMAO) play a role?
Arrona Cardoza, P., Spillane, M. B., & Morales Marroquin, E. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuab022 · Cited by 53 · see citing works
The Gut Microbial Metabolite Trimethylamine N-oxide, Incident CKD, and Kidney Function Decline
Wang, M., Tang, W. H. W., Li, X. S., Otto, M. C. D. O., Lee, Y., Lemaître, R. N., Fretts, A. M., Nemet, I., Sotoodehnia, N., Sitlani, C. M., et al. (2024) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000344 · Cited by 60 · see citing works
Gut microbiota dependant trimethylamine N-oxide and hypertension
Mutengo, K. H., Masenga, S. K., Mweemba, A., Mutale, W., & Kirabo, A. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1075641 · Cited by 52 · see citing works
“Trimethylamine from the gut reaches the liver by portal circulation, where host hepatic FMO3 incorporates oxygen atoms into trimethylamine to form TMAO (Gątarek and Kałużna-Czaplińska, 2021).”
BackgroundInfluentialChen, Y., Yang, C. H., Dai, Q., Tan, J., Dou, C., & Luo, F. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01872-9 · Cited by 50 · see citing works
“Trimethylamine-N-oxide (TMAO), a gut microbial-dependent metabolite of dietary choline, has been demonstrated to have a close correlation with multiple diseases such as cardiovascular disease, cancer, and kidney disease [12, 13].”
BackgroundMechanisms of hepatic and renal injury in lipid metabolism disorders in metabolic syndrome
Rong, J., Zhang, Z., Peng, X., Li, P., Zhao, T., & Zhong, Y. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.100394 · Cited by 54 · see citing works
“TMAO is excreted from the body through the kidneys [130].”
Background
- Authors
- Zeisel, S. H., & Warrier, M.
- Affiliations
- University of North Carolina System (US)
- Corresponding author
- Zeisel, Steven H.
- ORCID
- Zeisel, Steven H.
- Venue
- Annual Review of Nutrition
- Publisher
- Annual Reviews
- Published
- 2017-08-21
- Volume
- 37
- Issue
- 1
- Pages
- 157-181
- ISSN
- 0199-9885 (ISSN-L)
- 1545-4312
- OpenAlex
- W2566137938
- Cited by
- 475
- References
- 133
- Citations by year
- 2026: 25 · 2025: 60 · 2024: 57 · 2023: 75 · 2022: 64 · 2021: 70 · 2020: 51 · 2019: 42 · 2018: 26 · 2017: 4
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annual Review of Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Polyamine Metabolism and Applications
- Keywords
- trimethylamine N-oxide, trimethylamine, gut microbiota, cardiovascular disease, heart disease, kidney disease, atherosclerosis, flavin-dependent monooxygenase, L-carnitine, choline, food sources, myocardial infarction, stroke
- MeSH terms
- Animals, Bacteria, Diet, Female, Heart Diseases, Humans, Kidney Diseases, Liver, Male, Methylamines, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review